Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
44816808	li-cxcl13	— (—)	1328	1419	100.00%	Distribution not available
44816808	li-cxcl13	ng/l (ng/l)	391	428	5.37%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other spirochaetal diseases

377

384

10.05

307.65

1.1

1150.20

476.32

ng/l

0.80

107

Lyme disease

375

376

10.22

307.65

1.1

1150.20

487.22

ng/l

0.78

107

Other spirochaetal diseases

375

379

10.13

307.65

1.1

1150.20

481.69

ng/l

0.79

107

Spirochaetal infections, other/unspecified

303

38.98

307.65

1.1

1279.86

502.43

ng/l

0.83

Spirochaetal infections, other/unspecified

377

379

10.19

307.65

1.1

1150.20

481.71

ng/l

0.79

107

Inflammatory diseases of the central nervous system

208

22.96

283.43

1.2

1.1

353.81

632.68

ng/l

0.34

106

Neurological diseases

427

314

6.87

196.90

1.1

246.46

176.72

ng/l

0.29

Symptoms and signs involving the nervous and musculoskeletal systems

416

841

5.00

191.76

1.1

152.14

721.45

ng/l

1.75

215

Viral infections of the central nervous system

154

16.60

181.57

1.2

1.1

91.69

311.26

ng/l

0.83

Polyneuropathies and other disorders of the peripheral nervous system

228

270

8.62

177.57

1.1

628.25

502.93

ng/l

0.17

Encephalitis

109

40.03

177.19

1.3

1.0

301.51

29.00

ng/l

—

Viral infections of the central nervous system

146

17.37

176.04

1.2

1.1

91.69

324.18

ng/l

0.85

Headache

400

645

4.99

170.49

1.1

147.76

679.67

ng/l

1.33

154

Other and unspecified polyneuropathies, also in other diseases

199

239

8.50

153.29

1.1

690.72

569.35

ng/l

0.14

Other symptoms and signs involving the nervous and musculoskeletal systems

299

582

5.19

144.24

1.2

1.1

58.65

537.57

ng/l

1.87

141

Meningitis

111

19.85

142.17

1.2

1.1

524.11

37.67

ng/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

527

1004

3.60

140.85

1.1

335.15

629.25

ng/l

0.72

254

Other degenerative diseases of the nervous system

168

108

11.73

139.24

1.1

94.92

308.43

ng/l

0.66

Other symptoms and signs involving cognitive functions and awareness

282

496

5.22

132.77

1.1

348.57

781.11

ng/l

0.61

133

Epilepsy

219

377

5.85

120.35

1.1

847.41

235.75

ng/l

0.61

Bell's palsy

134

137

10.01

116.91

1.1

980.39

251.65

ng/l

0.84

Abnormal findings on diagnostic imaging of central nervous system

17.83

112.33

1.1

504.61

337.45

ng/l

0.16

Neurological diseases, wide definition

169

12.20

110.46

1.1

1.0

217.97

87.40

ng/l

0.76

General symptoms and signs

492

719

3.44

110.44

1.1

454.35

642.37

ng/l

0.26

104

171

Fever of other and unknown origin

279

585

4.27

102.88

1.1

484.79

711.03

ng/l

0.26

145

Disturbances of skin sensation

209

405

5.22

101.59

1.1

688.18

292.76

ng/l

0.27

Certain infectious and parasitic diseases

414

593

3.51

95.60

1.1

512.30

85.32

ng/l

1.35

108

Intracranial trauma

198

248

5.64

91.51

1.1

105.80

200.74

ng/l

0.56

Malaise and fatigue

251

470

4.32

91.00

1.1

226.11

739.96

ng/l

0.84

122

Concussion

169

245

5.65

83.48

1.1

100.94

200.74

ng/l

0.58

Convulsions, not elsewhere classified

146

241

6.04

82.76

1.1

85.24

327.77

ng/l

1.13

Nerve, nerve root and plexus disorders

477

1060

2.77

81.21

1.1

500.42

576.99

ng/l

0.11

109

242

Visual disturbances and blindness

276

787

3.53

80.66

1.1

1041.99

496.79

ng/l

0.54

191

Focal epilepsy

154

301

5.18

74.21

1.2

1.1

676.81

378.75

ng/l

0.21

Demyelinating diseases of the central nervous system

114

8.52

73.39

1.1

108.09

461.62

ng/l

0.86

Medical observation and evaluation for suspected diseases and conditions

307

442

3.57

73.27

1.1

667.43

406.23

ng/l

0.29

115

Focal epilepsy, strict definition

147

280

5.32

72.97

1.2

1.1

716.09

399.75

ng/l

0.21

Visual disturbances

252

735

3.45

71.27

1.1

1073.17

438.63

ng/l

0.61

176

Condition for Implicit Sepsis (Organ dysfunction codes)

387

976

2.81

70.76

1.1

581.25

586.54

ng/l

0.01

242

Condition for Implicit Sepsis (Organ dysfunction codes)

401

1021

2.72

68.54

1.1

536.80

596.44

ng/l

0.06

244

Focal epilepsy, mode (most common among epilepsy diagnosis)

138

265

5.27

67.91

1.2

1.1

748.28

417.28

ng/l

0.21

Other neurological diseases

335

909

2.91

67.18

1.2

1.1

464.30

664.05

ng/l

0.24

215

Dizziness and giddiness

315

847

2.96

65.30

1.1

352.15

667.23

ng/l

0.64

224

Implicit Sepsis

362

966

2.75

64.31

1.1

636.45

560.73

ng/l

0.07

240

Symptoms and signs involving the skin and subcutaneous tissue

321

1122

2.81

63.86

1.1

665.62

538.07

ng/l

0.12

268

Migraine

231

553

3.40

60.57

1.1

152.87

209.66

ng/l

0.27

126

Episodal and paroxysmal disorders

433

871

2.54

59.29

1.1

549.58

349.13

ng/l

0.34

203

Postprocedural disorders of nervous system

8.94

57.08

1.1

31.32

359.07

ng/l

—

Other demyelinating diseases of the central nervous system

13.36

55.61

1.2

1.1

185.69

576.13

ng/l

—

Pain, not elsewhere classified

128

278

4.63

54.53

1.1

946.00

280.38

ng/l

0.39

Infections, IBD-co-morbidities

12.37

51.65

1.1

1.0

412.21

85.50

ng/l

—

Abnormalities of gait and mobility

133

6.41

50.72

1.1

453.80

402.48

ng/l

0.04

Implicit Sepsis

315

926

2.58

49.87

1.1

676.84

595.81

ng/l

0.07

224

MS-disease / Multiple Sclerosis

7.97

49.85

1.1

36.68

394.69

ng/l

0.81

Viral meningitis

13.93

49.51

1.2

1.1

127.65

221.00

ng/l

—

Diplopia

149

5.91

48.55

1.2

1.1

2359.88

255.50

ng/l

1.13

Certain infectious and parasitic diseases

264

443

2.99

48.45

1.1

364.70

99.30

ng/l

1.32

Other soft tissue disorders, not elsewhere classified

377

930

2.38

47.55

1.1

548.97

442.79

ng/l

0.13

226

Cerebrovascular diseases (FINNGEN)

175

349

3.57

47.30

1.1

512.44

348.99

ng/l

0.20

Myalgia

124

296

4.22

46.94

1.1

103.29

350.93

ng/l

1.78

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

124

120

5.20

45.48

1.1

244.16

309.66

ng/l

0.16

Speech disturbances, not elsewhere classified

101

6.94

44.92

1.2

1.1

605.13

481.30

ng/l

0.09

Dorsalgia

375

869

2.32

43.43

1.1

879.41

461.34

ng/l

0.59

217

Implicit viral Sepsis

141

393

3.61

42.96

1.1

141.56

466.91

ng/l

1.02

Disorders of optic nerve and visual pathways

125

6.01

41.95

1.2

1.1

94.33

258.21

ng/l

0.73

Cerebrovascular diseases

289

830

2.46

40.89

1.1

692.37

670.43

ng/l

0.02

199

Low back pain

282

832

2.44

39.66

1.1

576.47

475.41

ng/l

0.14

210

Viral Sepsis

108

265

4.11

39.50

1.1

164.55

603.21

ng/l

0.98

Implicit viral Sepsis

107

264

4.09

38.86

1.1

164.55

612.20

ng/l

0.99

Other headache syndromes

165

543

3.05

38.45

1.1

94.35

248.94

ng/l

1.39

140

Pain in joint

213

484

2.82

38.32

1.1

294.81

560.71

ng/l

0.41

133

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

257

956

2.41

37.15

1.1

337.97

670.18

ng/l

0.69

225

Subjective visual disturbances

122

344

3.57

36.64

1.1

68.00

336.39

ng/l

2.03

Pain (limb, back, neck, head abdominally)

258

504

2.57

36.38

1.1

450.15

553.28

ng/l

0.12

134

Bacterial infection, other or unspecified

216

726

2.59

36.03

1.1

722.84

739.93

ng/l

0.01

151

Other dorsopathies, not elsewhere classified

360

871

2.17

35.66

1.1

750.87

461.34

ng/l

0.39

217

STROKE

239

650

2.51

35.16

1.1

399.86

606.99

ng/l

0.27

156

Pain in limb

302

898

2.26

35.11

1.1

683.11

451.96

ng/l

0.24

221

Autoimmune diseases excluding thyroid diseases

385

1012

2.08

34.85

1.1

312.99

507.47

ng/l

0.48

110

203

Disorders of thyroid, IBD co-morbidities

8.28

34.77

1.1

1043.27

85.92

ng/l

0.58

Bacterial infection, other or unspecified

229

783

2.48

34.75

1.1

712.69

671.55

ng/l

0.04

170

Lower back pain or/and sciatica

381

1225

2.04

34.10

1.1

540.61

546.00

ng/l

0.01

295

Autoimmune diseases excluding thyroid diseases, strict definition

372

980

2.08

33.85

1.1

326.20

515.53

ng/l

0.44

104

198

Migraine without aura

234

4.04

33.76

1.1

52.31

79.23

ng/l

0.37

Examination and observation for other reasons

205

439

2.71

33.48

1.1

550.66

412.53

ng/l

0.20

113

Other disorders of optic [2nd] nerve and visual pathways

6.92

33.12

1.2

1.1

65.74

270.90

ng/l

0.73

Cerebral cysts

7.42

31.84

1.2

1.1

2364.11

368.79

ng/l

—

ILD medications

399

1093

1.98

31.81

1.1

419.52

610.03

ng/l

0.32

100

224

Syncope and collapse

150

438

2.94

31.77

1.1

867.87

806.17

ng/l

0.03

112

General examination and investigation of persons without complaint and reported diagnosis

218

442

2.58

31.47

1.1

468.28

406.23

ng/l

0.07

115

Abnormal involuntary movements

155

4.69

31.22

1.1

814.67

410.36

ng/l

—

Systemic connective tissue disorders

147

513

2.88

31.06

1.1

213.97

468.91

ng/l

0.65

119

ILD medications: prednisolone, methylprednisolone, prednisone

380

1069

1.99

30.95

1.1

478.80

614.85

ng/l

0.20

222

Implicit bacterial Sepsis

169

542

2.70

30.70

1.1

999.61

608.67

ng/l

0.29

138

Any gastric operation

278

614

2.28

30.56

1.1

282.94

280.69

ng/l

0.01

120

GASTRO-related operations

278

614

2.28

30.56

1.1

282.94

280.69

ng/l

0.01

120

Stroke, including SAH

229

704

2.37

30.38

1.1

625.76

766.89

ng/l

0.13

170

Implicit bacterial Sepsis

155

501

2.75

29.36

1.1

1051.97

575.73

ng/l

0.35

128

ILD medications: immunosuppressive drugs

239

997

2.23

29.28

1.2

1.1

315.84

658.96

ng/l

0.76

205

Migraine with aura

278

3.54

29.24

1.1

142.84

141.18

ng/l

0.01

Stroke, excluding SAH

215

662

2.38

28.90

1.2

1.1

649.98

798.41

ng/l

0.13

162

Malignant neoplasm of brain, including Hilmo

7.00

28.89

1.1

956.87

115.99

ng/l

0.74

Autoimmune diseases related-to ILD

307

1301

2.02

28.73

1.1

246.85

618.88

ng/l

1.17

273

Dorsopathies

347

879

2.01

28.30

1.1

465.60

459.31

ng/l

0.01

218

Small fibre neuropathy

10.61

28.11

1.2

1.1

37.22

510.71

ng/l

—

Cerebral palsy and other paralytic syndromes

147

4.54

27.50

1.1

117.92

439.91

ng/l

0.94

Ischaemic Stroke, excluding all haemorrhages

196

607

2.41

27.30

1.2

1.1

332.00

786.45

ng/l

0.68

152

Bacterial Sepsis

169

571

2.54

27.10

1.2

1.1

898.51

585.21

ng/l

0.25

144

Optic neuritis

8.15

26.93

1.2

1.1

124.54

62.71

ng/l

—

Dysphagia

103

320

3.24

26.70

1.2

1.1

570.74

750.52

ng/l

0.13

Opioids

335

882

1.98

26.30

1.1

525.60

466.70

ng/l

0.06

211

Oral corticosteroids

364

1143

1.89

26.11

1.1

524.72

590.41

ng/l

0.09

248

Malignant neoplasm of brain

8.14

26.08

1.1

1090.77

187.99

ng/l

—

First line medication for Crohn's disease

373

1068

1.89

26.07

1.1

777.43

459.71

ng/l

0.41

218

Diagnoses used for exclusion with ILD

110

363

3.05

25.78

1.2

1.1

345.09

437.33

ng/l

0.12

Symptoms and signs involving speech and voice

134

495

2.72

25.54

1.1

403.34

580.02

ng/l

0.22

119

Other antidepressants

349

929

1.93

25.47

1.1

649.22

470.36

ng/l

0.24

227

Diseases of the eye and adnexa

285

687

2.08

25.45

1.1

263.69

334.46

ng/l

0.18

141

Inflammatory bowel disease treatment related agents

389

1183

1.84

25.36

1.1

483.90

577.42

ng/l

0.14

254

Other special examinations and investigations of persons without complaint or reported diagnosis

207

442

2.38

25.20

1.1

706.23

406.23

ng/l

0.45

115

Persons encountering health services for examination and investigation

208

442

2.37

24.99

1.1

423.27

406.23

ng/l

0.03

115

Used for control exclusion in common control thyroid runs

351

932

1.91

24.72

1.1

449.10

505.15

ng/l

0.08

186

Paralytic strabismus

5.62

24.45

1.1

1075.82

332.68

ng/l

—

Other bacterial diseases

320

1130

1.91

24.21

1.1

663.78

556.92

ng/l

0.14

234

Enlarged lymph nodes

160

4.09

23.82

1.1

646.29

274.84

ng/l

0.45

Sciatica+with lumbago

174

688

2.33

23.72

1.1

633.21

505.21

ng/l

0.11

184

Visual impairment including blindness (binocular or monocular)

6.23

23.64

1.1

438.71

84.74

ng/l

—

Diseases of the myoneural junction and muscle

157

4.11

23.60

1.2

1.1

480.13

226.15

ng/l

0.28

Soft tissue disorders

343

941

1.88

23.35

1.1

560.60

442.79

ng/l

0.13

226

Nausea and vomiting

105

355

2.91

22.67

1.2

1.1

381.44

685.81

ng/l

0.29

Somatoform disorder

204

3.60

22.41

1.1

62.67

407.42

ng/l

1.32

Tramadol

261

802

2.00

22.31

1.1

779.41

498.80

ng/l

0.30

195

Autoimmune diseases

363

1018

1.82

22.19

1.1

387.36

507.47

ng/l

0.22

203

Radiculopathy

187

3.71

22.15

1.1

873.33

287.38

ng/l

0.34

Organic, including symptomatic, mental disorders

169

514

2.35

22.10

1.1

439.96

695.03

ng/l

0.29

143

Anxiety disorders, excluding more controls

279

939

1.94

21.99

1.1

296.72

457.31

ng/l

0.33

229

Other necrotizing vasculopathies (FG)

6.02

21.69

1.1

201.60

615.06

ng/l

0.50

Other disorders of eye and adnexa

196

3.60

21.45

1.2

1.1

313.67

426.84

ng/l

0.16

Other intervertebral disc disorders

258

785

1.98

21.35

1.1

382.15

491.78

ng/l

0.15

201

Delirium, not induced by alcohol and other psychoactive substances

134

4.20

21.29

1.1

450.25

459.55

ng/l

—

Other systemic involvement of connective tissue (FG)

100

344

2.88

21.29

1.1

61.60

1054.00

ng/l

1.35

Malignant neoplasm of eye, brain and central nervous system

6.36

21.04

1.1

1090.77

159.63

ng/l

0.69

Spondylopathies

245

730

2.01

21.00

1.1

1182.38

490.63

ng/l

0.76

190

Persons encountering health services for specific procedures and health care

358

1216

1.77

20.89

1.1

481.75

585.56

ng/l

0.13

265

Non-Hodgkin lymphoma, all, including Hilmo

175

3.69

20.33

1.2

1.1

1755.58

476.59

ng/l

0.92

Migraine without aura and triptan purchases

223

3.34

20.27

1.1

52.31

776.71

ng/l

1.05

Other bacterial diseases

331

1180

1.78

20.14

1.1

641.81

536.14

ng/l

0.14

244

Certain disorders involving the immune mechanism

292

3.00

19.93

1.2

1.1

661.08

354.76

ng/l

0.32

Second line medication for Crohn's disease

202

997

2.03

19.86

1.2

1.1

358.21

717.28

ng/l

0.78

222

Cervicalgia

251

3.16

19.85

1.1

1416.18

560.25

ng/l

0.26

Symptoms and signs involving the urinary system

251

1005

1.91

19.61

1.1

634.11

585.38

ng/l

0.05

246

Other specific joint derangements/joint disorders

256

866

1.91

19.55

1.1

256.94

454.77

ng/l

0.62

212

Neurotic, stress-related and somatoform disorders

299

1158

1.81

19.52

1.1

287.20

574.36

ng/l

0.62

265

Anxiety disorders

300

1162

1.80

19.32

1.1

287.20

628.22

ng/l

0.76

266

Symptoms and signs involving the digestive system and abdomen

326

914

1.79

19.05

1.1

348.56

676.64

ng/l

0.70

209

Other systemic involvement of connective tissue

102

386

2.66

18.69

1.1

58.50

584.43

ng/l

1.34

Codeine

292

873

1.82

18.40

1.1

219.77

468.88

ng/l

0.59

210

Provisional assignment of new diseases of uncertain etiology

176

852

2.07

18.22

1.1

115.41

426.15

ng/l

1.55

203

Other disorders of lacrimal gland

127

540

2.36

18.20

1.1

1326.66

644.04

ng/l

0.37

133

Codes for special purposes

176

854

2.06

18.11

1.1

115.41

426.15

ng/l

1.55

203

Other necrotizing vasculopathies

4.82

18.00

1.1

204.37

523.80

ng/l

0.44

Sarcoidosis

195

3.36

17.99

1.2

1.1

551.11

441.09

ng/l

0.08

Oedema, not elsewhere classified

322

2.77

17.86

1.1

589.14

707.11

ng/l

0.06

Trigeminal neuralgia

5.66

17.74

1.1

1123.50

153.21

ng/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

165

783

2.10

17.68

1.1

743.25

405.79

ng/l

0.38

176

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

316

1263

1.73

17.68

1.1

779.11

479.14

ng/l

0.38

276

Ocular pain

108

4.21

17.17

1.2

1.1

486.33

500.69

ng/l

0.01

Non-Hodgkin lymphoma, all

5.83

17.14

1.3

1.1

2282.75

48.68

ng/l

1.00

Other diseases of spinal cord

7.63

17.01

1.3

1.1

106.67

233.86

ng/l

—

Other viral diseases

138

621

2.21

17.00

1.1

96.03

377.04

ng/l

1.02

136

L04AX Other immunosuppressants

191

981

1.95

16.87

1.2

1.1

388.03

714.65

ng/l

0.65

221

Non-follicular lymphoma

123

3.94

16.79

1.2

1.1

2001.00

419.03

ng/l

0.88

Liquid cancers, helper endpoint

132

510

2.27

16.78

1.2

1.1

1102.96

798.11

ng/l

0.22

117

Benzodiazepine use

317

1285

1.70

16.78

1.1

1197.86

436.53

ng/l

0.50

306

Exclusions for E4_PCOS_BROAD

267

2.90

16.69

1.1

724.24

312.44

ng/l

0.56

Primary_lymphoid and hematopoietic malignant neoplasms

340

2.66

16.61

1.2

1.1

1474.73

445.59

ng/l

0.91

Cervicobrachial syndrome

278

2.82

16.10

1.1

118.00

529.47

ng/l

0.80

Other reaction to severe stress, and adjustment disorders

128

579

2.22

15.93

1.1

619.39

415.47

ng/l

0.19

126

Cervical disc disorders

118

517

2.29

15.85

1.1

665.24

573.40

ng/l

0.08

144

Systemic atrophies primarily affecting the central nervous system

5.54

15.74

1.1

17.18

296.35

ng/l

—

Other disorders of fluid, electrolyte and acid-base balance

106

422

2.40

15.70

1.1

523.80

661.44

ng/l

0.17

Cardiovascular diseases (excluding rheumatic etc)

214

650

1.90

15.61

1.1

175.69

321.55

ng/l

0.82

141

Recurrent or chronic depression

132

416

2.24

15.60

1.1

2475.47

496.19

ng/l

0.45

116

Parasetamol

239

661

1.84

15.29

1.1

256.18

530.10

ng/l

0.68

147

Anaemias

176

2.90

15.26

1.1

147.22

293.20

ng/l

0.40

Pneumonitis due to solids and liquids

4.27

15.24

1.2

1.1

89.36

242.36

ng/l

0.60

Other/unspecified dorsalgia

114

496

2.29

15.24

1.1

828.82

577.86

ng/l

0.20

137

Disorders of lacrimal system

142

680

2.09

15.20

1.1

1111.88

587.34

ng/l

0.33

162

Gastro-oesophageal reflux disease

219

1044

1.81

15.13

1.1

441.67

625.68

ng/l

0.28

251

Mood disorders, excluding more controls

286

999

1.71

15.10

1.1

946.63

436.33

ng/l

0.29

246

Cardiovascular diseases

201

562

1.93

15.10

1.1

245.25

254.87

ng/l

0.03

117

Diseases of the musculoskeletal system and connective tissue

169

411

2.07

15.07

1.1

241.00

195.02

ng/l

0.13

104

Metabolic disorders

292

1052

1.70

15.00

1.1

554.42

625.04

ng/l

0.07

233

Abdominal and pelvic pain

307

914

1.69

14.87

1.1

336.80

676.64

ng/l

0.71

209

Chronic laryngitis and laryngotracheitis

183

3.19

14.87

1.1

1182.36

321.60

ng/l

—

Codeine or tramadol medication

347

1170

1.63

14.80

1.1

449.87

584.55

ng/l

0.17

278

Other disorders of urethra and urinary system

216

856

1.83

14.74

1.1

682.27

373.20

ng/l

0.23

207

Abnormalities of breathing

277

939

1.72

14.70

1.1

629.79

347.17

ng/l

0.46

221

Sequelae of cerebrovascular disease

109

407

2.32

14.66

1.1

249.64

363.56

ng/l

0.27

104

Intracranial injury

186

938

1.88

14.63

1.1

90.31

757.21

ng/l

2.46

216

Strabismus

100

422

2.37

14.60

1.1

628.73

232.31

ng/l

0.50

COPD differential diagnosis

238

661

1.81

14.49

1.1

426.08

645.10

ng/l

0.30

147

ILD differential diagnosis

238

661

1.81

14.48

1.1

426.08

645.10

ng/l

0.30

147

Extrapyramidal and movement disorders

120

552

2.18

14.38

1.1

2353.84

575.30

ng/l

0.46

131

Covid-19 confirmed case

119

547

2.18

14.29

1.1

122.67

434.38

ng/l

1.51

133

Finngen Rheumatological endpoints

300

1025

1.67

14.27

1.1

177.39

609.25

ng/l

1.51

236

Depression medications

180

2.63

14.24

1.1

77.78

293.20

ng/l

0.71

Other viral diseases, not elsewhere classified

100

426

2.34

14.20

1.0

1.1

113.27

484.21

ng/l

0.88

Pain in throat and chest

262

916

1.72

14.15

1.1

920.83

348.64

ng/l

0.53

220

Other diseases of intestines

329

1154

1.62

14.14

1.1

335.15

485.14

ng/l

0.41

261

Other and unspecified myopathies

108

3.83

13.85

1.1

540.07

247.69

ng/l

0.28

Spondylosis

158

659

1.96

13.73

1.1

487.00

522.07

ng/l

0.04

173

Disorders of eyelid, lacrimal system and orbit

259

1167

1.69

13.70

1.1

714.02

516.89

ng/l

0.22

283

Traumatic subdural haemorrhage

5.18

13.64

1.1

77.00

290.55

ng/l

—

Injuries to the head

340

1320

1.59

13.51

1.1

168.85

627.31

ng/l

1.97

293

Other viral diseases

106

476

2.23

13.41

1.1

111.34

246.78

ng/l

0.88

106

Asthma (mode)

221

661

1.79

13.40

1.1

219.68

645.10

ng/l

0.79

147

Hypertensive diseases (excluding secondary)

172

520

1.93

13.24

1.1

384.48

355.71

ng/l

0.05

125

Excluding asthma or asthma-COPD overlap

234

666

1.76

13.20

1.1

419.47

645.56

ng/l

0.31

147

Any mental disorder

327

1021

1.61

13.11

1.1

725.26

426.86

ng/l

0.39

252

Temporal arteritis

5.98

13.08

1.1

1.2

54.00

45.13

ng/l

—

Other pulmonary diagnosis

233

666

1.76

12.97

1.1

417.21

645.56

ng/l

0.31

147

Asthma

221

656

1.77

12.78

1.1

219.32

649.52

ng/l

0.79

146

Other functional intestinal disorders

145

692

1.95

12.75

1.1

250.33

546.35

ng/l

0.74

164

Complications of surgical and medical care, not elsewhere classified

296

1264

1.61

12.71

1.1

138.92

636.84

ng/l

2.44

294

Diffuse large B-cell lymphoma, helper endpoint

4.81

12.62

1.3

1.1

2556.67

47.61

ng/l

1.00

Diffuse large B-cell lymphoma, including Hilmo

4.81

12.62

1.3

1.1

2556.67

47.61

ng/l

1.00

Diffuse large B-cell lymphoma

4.81

12.62

1.3

1.1

2556.67

47.61

ng/l

1.00

Symptoms and signs involving the circulatory and respiratory systems

304

944

1.62

12.52

1.1

280.64

345.71

ng/l

0.15

222

Giant cell arteritis with polymyalgia rheumatica

5.69

12.44

1.1

54.00

45.13

ng/l

—

Oxycodone

117

508

2.09

12.41

1.1

1576.12

615.39

ng/l

0.52

132

Influenza and pneumonia

320

1296

1.57

12.40

1.1

628.05

531.63

ng/l

0.13

280

Other and unspecified visual disturbances

117

3.53

12.36

1.1

90.13

264.20

ng/l

—

Asthma, excluding more controls

215

637

1.76

12.30

1.1

223.75

667.84

ng/l

0.79

141

Viral infections characterized by skin and mucous membrane lesions

133

679

1.96

12.11

1.2

1.1

277.72

516.44

ng/l

0.62

155

Disorders of lipoprotein metabolism and other lipidaemias

241

890

1.68

12.10

1.1

252.39

673.75

ng/l

1.03

200

Giant cell arteritis

5.28

12.03

1.1

86.00

612.36

ng/l

—

Depression or dysthymia

192

589

1.80

11.99

1.1

2927.10

564.28

ng/l

0.73

163

Sixth [abducent] nerve palsy

5.72

11.97

1.0

1.1

688.33

115.50

ng/l

—

Coxibs

192

2.45

11.96

1.1

263.35

404.31

ng/l

0.26

Pneumonia, organism unspecified

276

1206

1.61

11.95

1.1

722.90

550.00

ng/l

0.22

264

Special screening examination for infectious and parasitic diseases

201

2.61

11.92

1.1

137.17

348.22

ng/l

0.97

Fibromyalgia

3.83

11.89

1.1

36.80

515.35

ng/l

—

Other and unspecified nerve root and plexus disorders, also in other diseases

266

2.57

11.84

1.0

1.1

221.15

631.58

ng/l

0.56

Pure hypercholesterolaemia

213

817

1.70

11.44

1.1

216.97

709.17

ng/l

1.21

184

Diseases of oesophagus, stomach and duodenum

313

1207

1.55

11.41

1.1

253.18

609.66

ng/l

1.14

275

Hypo-osmolality and hyponatraemia

230

2.65

11.31

1.1

755.45

449.24

ng/l

0.40

Lumbar disc prolapse

175

755

1.78

11.31

1.1

81.15

502.41

ng/l

1.30

196

Other extrapyramidal and movement disorders in other diseases

334

2.35

11.21

1.1

2624.06

400.71

ng/l

0.53

Shoulder lesions

217

778

1.69

11.20

1.1

620.28

472.25

ng/l

0.15

199

Explicit Sepsis

122

580

1.97

11.13

1.2

1.1

885.58

530.05

ng/l

0.23

144

Mood disorders

303

1267

1.55

11.13

1.1

946.63

496.16

ng/l

0.25

300

Other shoulder lesions

106

3.51

11.12

1.1

72.32

388.58

ng/l

—

Other anxiety disorders

142

657

1.88

11.11

1.1

190.25

421.87

ng/l

0.57

146

Depression

285

1236

1.56

11.03

1.1

1033.75

502.58

ng/l

0.29

295

Benign neoplasm of brain and other parts of central nervous system

3.96

11.02

1.2

1.1

75.63

540.60

ng/l

—

Mood [affective] disorders

302

1268

1.55

10.98

1.1

966.96

494.62

ng/l

0.26

301

Fitting and adjustment of other devices

106

465

2.06

10.95

1.1

119.05

591.28

ng/l

1.93

110

Zoster [herpes zoster]

237

2.59

10.81

1.1

236.89

465.54

ng/l

0.67

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

260

987

1.60

10.75

1.1

670.54

493.02

ng/l

0.23

222

260

987

1.60

10.75

1.1

670.54

493.02

ng/l

0.23

222

All kidney diseases

292

1296

1.54

10.63

1.1

150.24

652.26

ng/l

2.31

283

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

157

859

1.78

10.56

1.1

540.51

484.08

ng/l

0.04

203

Symptoms and signs concerning food and fluid intake

3.55

10.42

1.1

252.71

192.13

ng/l

—

Complications of medical and surgical care

214

1208

1.63

10.40

1.1

583.73

538.29

ng/l

0.03

287

Psychiatric diseases

283

906

1.57

10.37

1.1

431.57

428.43

ng/l

0.00

230

Transient ischemic attack

138

603

1.86

10.34

1.1

158.68

912.63

ng/l

1.70

155

Asthma, unspecified (mode), excluding more controls

143

584

1.84

10.20

1.1

290.73

710.13

ng/l

0.61

131

Candidiasis

426

2.12

10.19

1.1

213.18

539.42

ng/l

0.68

Migraine with aura and triptan purchases

217

2.59

10.01

1.1

66.22

384.17

ng/l

—

Brachial plexus disorders

119

3.21

9.98

1.1

202.00

532.66

ng/l

—

Hydrocephalus

3.67

9.97

1.2

1.1

481.75

569.84

ng/l

—

Other general symptoms and signs

4.99

9.91

1.0

1.1

—

155.08

—

Vocal cord dysfunction

153

2.83

9.89

1.2

1.1

155.94

381.38

ng/l

0.78

Asthma, unspecified (mode)

144

600

1.81

9.87

1.1

290.73

688.90

ng/l

0.60

136

Herpesviral [herpes simplex] infections

157

2.88

9.83

1.2

1.1

442.38

457.06

ng/l

0.02

Enthesopathies of lower limb, excluding foot

285

2.36

9.82

1.1

95.42

515.89

ng/l

0.84

Anxiety (asthma-related co-morbidities)

180

825

1.69

9.78

1.1

126.89

354.98

ng/l

0.91

200

Hard cardiovascular diseases

247

936

1.58

9.69

1.1

142.52

589.80

ng/l

1.57

221

Care involving use of rehabilitation procedures

187

1040

1.66

9.69

1.1

189.00

623.17

ng/l

1.53

235

Dermatitis

179

1070

1.67

9.68

1.1

379.21

611.93

ng/l

0.44

244

Abnormal findings on diagnostic imaging of lung

131

688

1.83

9.68

1.1

187.77

842.55

ng/l

1.59

169

Hypertension, essential

229

808

1.61

9.63

1.1

304.54

428.27

ng/l

0.28

196

Intestinal infectious diseases

273

1365

1.52

9.53

1.1

282.54

584.86

ng/l

0.83

298

Acute upper respiratory infections

295

1208

1.51

9.52

1.1

739.32

495.62

ng/l

0.26

281

Other viral diseases, not elsewhere classified

295

2.31

9.49

1.1

134.35

338.98

ng/l

0.86

Other and unspecified dermatitis

153

885

1.73

9.49

1.1

429.24

627.48

ng/l

0.30

212

Lung diseases due to external agents

155

2.85

9.45

1.2

1.1

89.36

526.68

ng/l

1.32

Other disorders of nervous system

3.70

9.43

1.2

1.1

358.20

626.73

ng/l

—

Other specified/unspecified arthritis

393

2.12

9.43

1.1

270.15

675.81

ng/l

0.67

Heartburn

134

3.00

9.40

1.1

157.25

218.71

ng/l

—

Injuries to the ankle and foot

209

1163

1.60

9.39

1.1

120.03

518.47

ng/l

2.49

269

Other diseases of urinary system

287

1067

1.51

9.32

1.1

807.73

369.71

ng/l

0.45

255

Septicaemia

115

572

1.88

9.32

1.2

1.1

965.23

613.56

ng/l

0.20

122

Follow-up examination after treatment for conditions other than malignant neoplasms

106

355

1.98

9.27

1.1

221.74

377.48

ng/l

0.32

Other diseases of blood and blood-forming organs, wide

331

2.21

9.25

1.1

1294.50

395.87

ng/l

0.40

Antihypertensive medication - note that there are other indications

184

579

1.69

9.22

1.1

157.50

254.54

ng/l

0.49

123

Retention of urine

398

2.01

9.20

1.2

1.1

642.25

574.35

ng/l

0.04

111

Selective serotonin reuptake inhibitors

273

933

1.53

9.16

1.1

472.16

470.36

ng/l

0.00

227

All anxiety disorders

182

872

1.65

9.14

1.1

135.59

374.63

ng/l

0.97

199

Cough

121

624

1.84

9.11

1.1

1086.33

362.45

ng/l

0.57

164

Triptan medication for migraine, min. 3 purchases

168

761

1.69

9.09

1.1

138.27

371.52

ng/l

0.84

170

Other joint disorders

259

886

1.54

9.09

1.1

269.80

451.28

ng/l

0.58

214

Diarrhoea and gastroenteritis of presumed infectious origin

203

1148

1.59

9.05

1.1

256.33

662.43

ng/l

0.98

253

Diseases of the ear and mastoid process

330

1133

1.46

8.92

1.1

333.23

642.20

ng/l

0.66

249

Persons encountering health services in other circumstances, wide

328

1155

1.46

8.91

1.1

201.75

551.41

ng/l

1.74

259

Trochanteric bursitis

166

2.72

8.90

1.1

41.00

378.90

ng/l

1.91

Disorders of other endocrine glands

129

712

1.79

8.90

1.1

539.96

348.79

ng/l

0.29

161

Dementia, including avohilmo

119

439

1.87

8.88

1.1

55.38

716.21

ng/l

1.44

125

Benign neoplasm of meninges

129

2.96

8.75

1.2

1.1

1196.11

472.03

ng/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

285

1312

1.48

8.75

1.1

672.14

525.04

ng/l

0.20

284

Fall on same level

331

1246

1.45

8.75

1.1

231.54

633.24

ng/l

1.36

282

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.78

8.75

1.2

1.1

37.40

325.06

ng/l

—

Factors influencing health status and contact with health services

181

2.22

8.74

1.1

1.0

245.26

238.57

ng/l

0.01

Other arthritis (FG)

460

1.98

8.70

1.1

259.71

659.36

ng/l

0.79

110

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

433

2.02

8.69

1.1

197.64

330.73

ng/l

0.44

Asthma (only as main-diagnosis)

186

656

1.64

8.65

1.1

100.66

649.52

ng/l

1.23

146

Hypothyroidism (congenital or acquired)

175

2.30

8.65

1.1

156.33

293.20

ng/l

0.36

Systemic lupus erythematosus

4.80

8.60

1.1

518.14

48.78

ng/l

—

Benign neoplasm: Cerebral meninges

115

3.06

8.54

1.1

1575.82

441.10

ng/l

—

Other infectious diseases

110

3.11

8.51

1.2

1.1

50.44

473.77

ng/l

—

All pneumoniae

290

1320

1.47

8.50

1.1

672.98

523.02

ng/l

0.21

285

Persons encountering health services in other circumstances

119

659

1.80

8.47

1.1

1372.61

529.36

ng/l

0.33

153

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.33

8.41

1.3

1.1

2665.58

90.38

ng/l

0.79

Disorders of vestibular function (Vertigo)

131

739

1.75

8.41

1.1

327.43

695.60

ng/l

0.53

174

Mycoses

405

2.03

8.38

1.1

237.86

336.23

ng/l

0.33

Pneumonias (Asthma/COPD co-morbidities)

287

1314

1.47

8.38

1.1

681.55

523.06

ng/l

0.22

285

Asthma (only as main-diagnosis), excluding more controls

182

637

1.64

8.32

1.1

100.66

667.84

ng/l

1.23

141

Sleep apnoea

265

1153

1.49

8.27

1.1

641.31

440.89

ng/l

0.28

274

Soft tissue disorders related to use, overuse and pressure

374

2.06

8.24

1.1

91.75

388.70

ng/l

2.18

100

ILD medications: azathioprine

215

2.43

8.19

1.2

1.1

436.63

281.69

ng/l

0.25

Other septicaemia

102

528

1.86

8.07

1.2

1.1

1195.78

659.71

ng/l

0.25

109

Hypothyroidism and >3 levothyroxin purchases

174

2.25

8.04

1.1

114.71

293.20

ng/l

0.51

Hypothyroidism, levothyroxine purchases

174

2.25

8.04

1.1

114.71

293.20

ng/l

0.51

Other symptoms and signs involving the digestive system and abdomen

211

2.43

8.03

1.1

242.55

574.58

ng/l

0.34

COPD/asthma related infections

289

987

1.47

7.98

1.1

352.80

493.02

ng/l

0.27

222

COPD/asthma/ILD related infections

289

987

1.47

7.98

1.1

352.80

493.02

ng/l

0.27

222

Inflammatory diseases of female pelvic organs

165

742

1.64

7.98

1.1

281.84

555.72

ng/l

0.42

154

Other infectious diseases

3.28

7.92

1.2

1.1

48.63

554.90

ng/l

—

Viral infections characterized by skin and mucous membrane lesions

242

1392

1.49

7.89

1.1

886.75

470.69

ng/l

0.31

304

Acute upper respiratory infections of multiple and unspecified sites

209

1007

1.54

7.84

1.1

1184.97

363.21

ng/l

0.59

238

Hypertensive diseases

227

839

1.53

7.83

1.1

310.60

416.29

ng/l

0.23

202

Other diseases of upper respiratory tract

303

1094

1.44

7.80

1.1

488.06

575.13

ng/l

0.11

252

Falls/tendency to fall

308

1071

1.44

7.77

1.1

253.00

501.96

ng/l

0.81

247

Other heart diseases

140

536

1.71

7.77

1.1

962.42

358.66

ng/l

0.34

124

Polymyalgia rheumatica

161

2.62

7.76

1.1

35.20

508.56

ng/l

—

Hypothyroidism, strict autoimmune

188

783

1.58

7.75

1.1

291.25

532.65

ng/l

0.44

162

Other disorders of glucose regulation and pancreatic internal secretion

106

3.04

7.72

1.1

53.71

241.48

ng/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

305

1155

1.44

7.69

1.1

112.45

551.41

ng/l

2.89

259

Hypertension

226

838

1.52

7.69

1.1

310.60

416.29

ng/l

0.23

202

Triptan medication for migraine, single purchase ok

219

978

1.52

7.60

1.1

107.05

529.27

ng/l

1.50

225

Migraine, single triptan purchase ok & required. ICD-code if available is included

219

978

1.52

7.60

1.1

107.05

529.27

ng/l

1.50

225

Hypothyroidism, drug reimbursement

115

2.65

7.49

1.1

86.17

83.74

ng/l

—

Arthropathies

259

889

1.48

7.46

1.1

247.18

451.28

ng/l

0.70

214

Diseases of inner ear

147

871

1.64

7.43

1.1

312.42

744.13

ng/l

0.75

207

Azathioprine

226

2.31

7.37

1.2

1.1

436.63

367.38

ng/l

0.09

Dementia

107

407

1.81

7.36

1.1

58.14

391.56

ng/l

1.54

113

Dermatitis and eczema

307

1347

1.41

7.32

1.1

473.40

550.70

ng/l

0.11

294

Other disorders of ear

252

1128

1.46

7.31

1.1

521.84

579.01

ng/l

0.07

265

Complications of procedures, not elsewhere classified

219

1215

1.49

7.28

1.1

85.00

644.81

ng/l

2.98

290

Conjunctivitis (acute, non atopic)

461

1.89

7.24

1.0

1.1

183.54

473.52

ng/l

0.76

113

SLE, strict definition

4.33

7.23

1.1

451.50

57.00

ng/l

—

SLE, ICD10

4.33

7.23

1.1

451.50

57.00

ng/l

—

SLE (Finngen)

5.82

7.23

1.1

518.14

800.38

ng/l

—

Rheumatism, unspecified

162

2.54

7.15

1.1

51.24

407.85

ng/l

—

Polyarthropathies

185

778

1.56

7.14

1.1

492.57

482.83

ng/l

0.01

198

Gastrointestinal diseases

171

535

1.60

7.09

1.1

280.28

302.75

ng/l

0.05

129

Abnormalities of heart beat

534

1.80

7.08

1.2

1.1

996.31

342.69

ng/l

0.44

140

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

111

638

1.74

7.06

1.0

1.1

171.18

385.77

ng/l

0.54

144

Renal tubulo-interstitial diseases

237

1208

1.46

7.01

1.1

160.27

628.26

ng/l

1.95

273

Restless leg syndrome

176

2.45

6.98

1.1

4171.00

480.39

ng/l

—

Hypoglycaemia, other or unspecified

3.23

6.97

1.1

27.20

301.35

ng/l

—

Iridocyclitis

351

2.00

6.94

1.1

83.81

367.93

ng/l

1.78

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

271

1236

1.43

6.94

1.2

1.1

649.19

538.57

ng/l

0.14

264

Polyuria

325

2.04

6.89

1.1

281.76

613.28

ng/l

0.59

310

1142

1.40

6.88

1.1

697.32

494.04

ng/l

0.24

263

Any reimbursement code in KELA

172

544

1.59

6.85

1.1

181.77

429.99

ng/l

0.74

108

Hypopituitarism

109

2.86

6.78

1.0

544.14

160.62

ng/l

—

Acute sinusitis

142

817

1.61

6.77

1.1

85.44

431.75

ng/l

2.11

189

All influenza

369

1.96

6.72

1.2

1.1

1130.86

397.08

ng/l

0.30

Endocrine, nutritional and metabolic diseases

226

772

1.48

6.71

1.1

266.29

420.33

ng/l

0.39

162

Intestinal infectious diseases

316

1302

1.39

6.70

1.1

264.28

604.27

ng/l

1.03

292

Chronic apical periodontitis

304

1241

1.40

6.69

1.1

512.27

562.30

ng/l

0.06

277

Pain associated with micturition

150

2.54

6.67

1.1

89.33

390.00

ng/l

—

Disorders of sclera, cornea, iris and ciliary body

148

936

1.58

6.66

1.1

277.82

528.02

ng/l

0.69

211

Diseases of the respiratory system

173

552

1.57

6.65

1.1

495.57

780.47

ng/l

0.32

116

Temporomandibular joint disorders, including avohilmo

123

734

1.66

6.59

1.1

201.35

352.78

ng/l

0.47

155

Pain in thoracic spine

175

2.41

6.58

1.1

24.43

728.18

ng/l

—

Injuries to the shoulder and upper arm

228

1269

1.45

6.55

1.1

672.05

531.94

ng/l

0.14

299

Sleep disorders (combined)

306

1158

1.39

6.42

1.1

818.19

427.38

ng/l

0.30

268

Disorders of psychological development

169

2.37

6.41

1.2

1.1

82.14

228.10

ng/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

249

1.98

6.41

1.1

20.99

406.08

ng/l

2.74

Disorders of lens

176

718

1.53

6.36

1.2

1.1

308.76

752.68

ng/l

0.85

162

Constipation

239

1156

1.43

6.32

1.1

229.74

627.49

ng/l

1.29

274

Disorders of choroid and retina

210

1019

1.47

6.30

1.1

217.47

709.58

ng/l

1.71

237

Adrenocortical insufficiency

3.87

6.27

1.0

1.1

182.86

55.45

ng/l

—

Degenerative diseases of the nervous system

315

1.87

6.22

1.1

24.88

569.49

ng/l

—

Undetermined asthma, excluding more controls

150

2.47

6.16

1.2

1.1

649.25

149.43

ng/l

—

Immunodeficiency with predominantly antibody defects

5.79

6.16

1.1

1079.00

438.88

ng/l

—

Functional dyspepsia

411

1.85

6.09

1.1

215.37

495.57

ng/l

0.50

Sensorineural hearing loss

194

891

1.48

6.07

1.1

579.29

667.30

ng/l

0.10

220

Conductive and sensorineural hearing loss

205

946

1.46

6.07

1.1

526.36

661.02

ng/l

0.17

228

Acute tubulo-interstitial nephritis

166

946

1.52

6.06

1.2

1.1

179.85

721.45

ng/l

1.75

221

Accidents

224

774

1.45

5.98

1.1

254.27

499.70

ng/l

0.64

188

Undetermined asthma

153

2.42

5.92

1.2

1.1

649.25

146.13

ng/l

—

Internal derangement of knee

102

605

1.68

5.86

1.1

144.82

549.50

ng/l

1.43

155

Presence of other devices

310

1.96

5.82

1.2

1.1

644.82

365.13

ng/l

0.21

All influenza (not pneumonia)

212

2.18

5.76

1.2

1.1

1948.00

126.10

ng/l

—

Spinal stenosis

118

553

1.62

5.69

1.2

1.1

1500.15

562.90

ng/l

0.69

148

Other external causes of accidental injury

222

774

1.44

5.69

1.1

259.44

499.70

ng/l

0.61

188

Diseases of tongue

2.98

5.68

1.1

89.00

256.48

ng/l

—

Herpesviral [herpes simplex] infections

371

1.86

5.66

1.1

395.00

500.74

ng/l

0.13

121

755

1.59

5.64

1.1

84.00

366.51

ng/l

1.37

169

Agranulocytosis

157

2.37

5.63

1.1

2730.67

468.42

ng/l

—

Diaphragmatic hernia

563

1.69

5.61

1.1

315.07

670.01

ng/l

0.44

146

Problems related to lifestyle

158

2.35

5.55

1.1

360.50

227.27

ng/l

—

Asthma and allergy, excluding more controls

150

2.38

5.52

1.1

38.33

655.46

ng/l

—

Diseases of the skin and subcutaneous tissue

274

999

1.38

5.51

1.1

654.06

520.94

ng/l

0.12

221

Other and unspecified disorders of skin and subcutaneous tissue

3.07

5.49

1.1

144.67

722.53

ng/l

—

Bronchitis

283

1313

1.36

5.47

1.1

825.30

485.73

ng/l

0.34

308

Other diseases of arteries and capillaries

117

2.58

5.45

1.1

129.79

266.92

ng/l

—

Disorders of the thyroid gland

244

1145

1.39

5.44

1.1

453.43

458.06

ng/l

0.01

262

Other bacterial intestinal infections

341

1.88

5.41

1.1

374.20

367.56

ng/l

0.01

Tongue abnormality

2.97

5.41

1.1

89.00

525.85

ng/l

—

Hypothyroidism, other/unspecified

229

1075

1.40

5.41

1.1

431.07

467.02

ng/l

0.05

248

Exposure to unspecified factor

266

1405

1.36

5.39

1.1

241.83

578.82

ng/l

1.06

317

Other enthesopathies

421

1.79

5.37

1.1

2736.46

304.88

ng/l

0.42

109

Asthma and allergy

152

2.34

5.37

1.1

38.33

638.84

ng/l

—

Anterior Iridocyclitis

315

1.91

5.32

1.2

1.1

76.28

358.81

ng/l

1.72

Zoster [herpes zoster]

122

768

1.57

5.32

1.1

1340.41

579.33

ng/l

0.33

175

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

392

1.81

5.30

1.2

1.1

95.08

391.91

ng/l

0.74

Cystitis

216

909

1.41

5.27

1.1

157.30

357.09

ng/l

1.18

218

Diseases of external ear

543

1.68

5.27

1.1

92.74

648.41

ng/l

1.75

120

Sleep apnoea, including avohilmo

263

1194

1.37

5.25

1.1

661.87

566.46

ng/l

0.10

275

Personality disorders, excluding more controls

366

1.83

5.25

1.1

71.64

379.79

ng/l

0.77

188

2.19

5.23

1.0

1.1

41.70

350.95

ng/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

215

2.10

5.18

1.1

165.50

656.14

ng/l

—

Mycoses

225

1414

1.38

5.18

1.1

238.43

581.32

ng/l

1.32

317

Irritable bowel syndrome

412

1.78

5.16

1.1

37.78

466.99

ng/l

—

Non-selective monoamine reuptake inhibitors

533

1.67

5.15

1.1

260.81

548.90

ng/l

0.59

137

Tobacco use

2.95

5.14

1.2

1.1

478.00

308.49

ng/l

—

Neoplasms

209

780

1.42

5.14

1.1

186.26

409.43

ng/l

0.77

166

Hernia of abdominal wall, postoperative

183

2.19

5.13

1.0

1.1

150.13

300.25

ng/l

—

Voice disturbances

406

1.78

5.11

1.1

139.48

522.38

ng/l

0.98

Pain and other conditions associated with female genital organs and menstrual cycle

286

1.90

5.10

1.1

77.44

103.29

ng/l

—

Abnormal findings on diagnostic imaging of other body structures

184

2.18

5.08

1.2

1.1

901.33

466.95

ng/l

0.23

Exposure to other specified factors

201

1315

1.40

5.07

1.1

191.02

498.30

ng/l

1.66

299

Impacted cerumen

134

2.40

5.04

1.2

1.1

64.30

412.30

ng/l

—

Chronic diseases of tonsils and adenoids

211

951

1.40

5.02

1.1

432.52

615.26

ng/l

0.26

215

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

559

1.65

4.99

1.1

760.08

432.46

ng/l

0.33

123

Other strabismus

328

1.86

4.99

1.1

88.70

175.18

ng/l

—

Dentofacial anomalies [including malocclusion]

186

1051

1.42

4.96

1.1

275.05

497.79

ng/l

0.53

229

External causes of morbidity and mortality

183

634

1.45

4.93

1.1

359.89

327.32

ng/l

0.06

152

Injuries to the thorax

112

716

1.57

4.93

1.1

149.50

644.91

ng/l

2.01

178

Infections with a predominantly sexual mode of transmission

492

1.69

4.92

1.1

67.54

447.02

ng/l

1.13

105

Any dementia, excluding more controls

323

1.73

4.92

1.1

58.77

431.29

ng/l

1.33

Hypothyreosis and Thyroxine purchase for inclusion criteria

235

1125

1.37

4.91

1.1

416.00

461.96

ng/l

0.07

259

Other disorders of eyelid

109

659

1.58

4.91

1.2

1.1

652.58

609.48

ng/l

0.03

157

Insulin, fast-acting

577

1.63

4.90

1.1

266.16

473.84

ng/l

0.62

129

Other medical care

113

650

1.57

4.89

1.1

902.91

836.68

ng/l

0.03

157

Unspecified fall

127

824

1.52

4.89

1.1

69.24

448.68

ng/l

2.10

199

Diarrhoea and gastroenteritis of presumed infectious origin

266

1308

1.34

4.84

1.1

239.26

604.89

ng/l

1.04

291

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

153

1037

1.46

4.81

1.1

103.67

573.99

ng/l

2.01

247

Speech and linguistic disorders, excluding more controls

2.65

4.79

1.2

1.1

95.83

389.06

ng/l

—

Use of hypnotics and sedatives

281

1213

1.33

4.74

1.1

728.24

423.01

ng/l

0.40

280

Rotator cuff syndrome

148

720

1.48

4.73

1.1

739.28

503.33

ng/l

0.19

185

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

100

2.57

4.73

1.2

1.1

21.00

315.06

ng/l

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

278

1.86

4.71

1.1

102.67

143.96

ng/l

—

Other bacterial intestinal infections

258

1.94

4.71

1.1

420.08

407.71

ng/l

0.01

Chronic sinusitis

108

693

1.56

4.69

1.1

223.50

486.42

ng/l

0.54

165

Deviated nasal septum

530

1.64

4.68

1.1

987.13

667.47

ng/l

0.18

131

Other complications of surgical and medical care, not elsewhere classified

127

2.37

4.64

1.1

57.60

440.69

ng/l

—

Other disorders of adrenal gland

3.12

4.64

1.0

1.1

182.86

48.66

ng/l

—

Other female pelvic inflammatory diseases

225

2.01

4.63

1.1

748.22

251.75

ng/l

—

Sicca syndrome [Sjögren]

103

2.54

4.62

1.1

29.67

679.00

ng/l

—

Unspecified urinary incontinence

103

2.54

4.62

1.2

1.1

114.67

423.69

ng/l

—

Otalgia

109

2.49

4.62

1.2

1.1

10.75

513.71

ng/l

—

Osteopathies and chondropathies

142

902

1.47

4.61

1.1

146.69

603.66

ng/l

1.45

212

Ptosis of eyelid

153

2.23

4.58

1.2

1.1

936.00

290.14

ng/l

—

Other cataract

104

500

1.58

4.55

1.1

702.15

945.00

ng/l

0.14

121

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

116

2.42

4.54

1.1

3088.14

470.53

ng/l

—

Other and unspecified anaemias

583

1.59

4.53

1.2

1.1

276.10

425.85

ng/l

0.42

139

Acute and subacute iridocyclitis

291

1.86

4.48

1.1

74.44

361.94

ng/l

1.61

Drug-induced neutropenia

2.54

4.46

1.2

1.1

3060.00

466.48

ng/l

—

Insulin, fast-acting or short human

592

1.59

4.45

1.1

266.16

416.85

ng/l

0.42

135

Other and unspecified tonsillitis

463

1.62

4.42

1.1

795.56

295.28

ng/l

0.40

104

Childhood asthma (age<16), excluding more controls

115

2.27

4.42

1.1

90.29

78.39

ng/l

—

Other anaemias

587

1.57

4.37

1.2

1.1

276.10

423.03

ng/l

0.42

140

Candidiasis

204

2.02

4.30

1.1

423.83

349.07

ng/l

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

101

2.49

4.29

1.0

1.1

21.40

370.42

ng/l

—

Injury of muscle and tendon at shoulder and upper arm level

544

1.60

4.28

1.1

1358.06

698.34

ng/l

0.31

136

Benign paroxysmal vertigo

429

1.68

4.27

1.1

122.53

542.15

ng/l

1.16

Diabetic retinopathy, excluding more controls

192

1.81

4.27

1.1

337.44

391.46

ng/l

0.12

Childhood asthma (age<16)

117

2.23

4.26

1.1

90.29

78.46

ng/l

—

Fissure and fistula of anal and rectal regions

362

1.74

4.26

1.0

1.1

3218.28

765.35

ng/l

0.34

Conjunctivitis

195

1191

1.37

4.24

1.1

174.33

499.28

ng/l

1.20

263

Disorders of conjunctiva

214

1274

1.35

4.24

1.1

544.55

563.81

ng/l

0.02

280

Hypokalaemia

159

2.15

4.20

1.2

1.1

81.00

281.56

ng/l

—

Asthma (diagnoses ohter than nonallergic)

222

1378

1.34

4.17

1.1

203.45

599.71

ng/l

1.45

309

Injuries to the abdomen, lower back, lumbar spine and pelvis

604

1.56

4.16

1.1

846.00

402.99

ng/l

0.41

144

Substance abuse, excluding more controls

133

779

1.46

4.15

1.1

679.85

480.93

ng/l

0.12

203

Aplastic and other anaemias

105

643

1.52

4.13

1.2

1.1

272.55

455.76

ng/l

0.58

153

Any death

154

777

1.42

4.10

1.1

883.45

708.89

ng/l

0.12

187

Continuous positive airway pressure

263

1.80

4.09

1.2

1.1

1558.68

299.07

ng/l

0.58

Misadventures to patients during surgical and medical care

195

2.01

4.06

1.1

294.33

556.32

ng/l

—

Menorrhagia

316

1.60

4.04

1.1

203.05

205.91

ng/l

0.01

Immunodeficiencies

2.77

4.02

1.1

911.50

226.99

ng/l

—

Diabetic neuropathy

129

2.24

4.00

1.2

1.1

809.20

278.30

ng/l

—

Infections with a predominantly sexual mode of transmission

603

1.53

3.99

1.1

60.40

412.08

ng/l

1.33

129

Other disorders of white blood cells

2.68

3.99

1.2

1.1

87.13

288.10

ng/l

—

Carpal tunnel syndrome

133

814

1.44

3.96

1.2

1.1

121.26

662.26

ng/l

1.61

192

Neuromuscular dysfunction of bladder

118

2.30

3.93

1.2

1.1

27.00

460.46

ng/l

—

Insulin, intermediate and long-acting

133

902

1.43

3.91

1.1

146.79

627.94

ng/l

2.37

209

Disorders of skin appendages

122

838

1.46

3.90

1.1

71.49

481.65

ng/l

2.03

182

Genitourinary diseases

161

572

1.41

3.90

1.1

156.53

266.15

ng/l

0.57

131

Glomerular diseases

276

1.82

3.90

1.1

171.67

424.21

ng/l

0.96

Mouth breathing

104

692

1.50

3.90

1.1

566.44

662.74

ng/l

0.08

166

Dental pulpitis, including avohilmo

239

1180

1.32

3.89

1.1

301.32

519.55

ng/l

0.52

273

Asthma-related infections

144

1000

1.41

3.89

1.1

260.31

558.25

ng/l

0.58

228

Asthma, hospital admission 2, infections

144

1000

1.41

3.89

1.1

260.31

558.25

ng/l

0.58

228

Bleeding

206

1094

1.34

3.87

1.1

775.30

585.76

ng/l

0.17

256

Any dementia

361

1.60

3.86

1.1

56.29

522.77

ng/l

1.87

Localized swelling, mass and lump of skin and subcutaneous tissue

465

1.62

3.86

1.2

1.1

1848.71

402.34

ng/l

0.57

112

Nontraumatic intracranial haemmorrhage

241

1.87

3.85

1.1

1406.92

394.77

ng/l

0.40

Allergic asthma (mode)

300

1.76

3.83

1.1

39.85

438.24

ng/l

0.72

Allergic asthma (mode), excluding more controls

300

1.76

3.83

1.1

39.85

439.23

ng/l

0.72

Benign neoplasm: Colon

127

843

1.44

3.82

1.1

515.72

733.62

ng/l

0.30

214

Other and unspecified drugs and medicaments

114

2.29

3.77

1.1

3088.14

448.72

ng/l

—

Senile cataract

148

642

1.41

3.77

1.2

1.1

327.30

806.43

ng/l

0.82

146

Tonsillectomy and adenotomy

147

727

1.41

3.75

1.1

581.20

373.63

ng/l

0.21

148

Hypothyroidism, strict autoimmune, 3 medication purchases required

203

1027

1.34

3.72

1.1

277.11

500.61

ng/l

0.48

230

Abnormal findings on examination of blood, without diagnosis

112

701

1.47

3.72

1.1

142.15

696.22

ng/l

2.24

172

Other disorders of skin and subcutaneous tissue

166

1078

1.37

3.72

1.1

662.86

573.92

ng/l

0.06

255

Presence of other functional implants

137

668

1.42

3.71

1.1

816.90

785.73

ng/l

0.02

154

Fracture of foot, except ankle

370

1.68

3.71

1.1

108.18

276.41

ng/l

1.01

Other disorders of skin and subcutaneous tissue, not elsewhere classified

195

1.95

3.71

1.1

2402.44

560.02

ng/l

—

Obesity related asthma

573

1.54

3.69

1.1

89.07

464.49

ng/l

1.39

130

Seronegative rheumatoid arthritis

148

2.10

3.67

1.1

214.91

478.36

ng/l

0.58

Asthma, including avohilmo

304

1348

1.27

3.66

1.1

226.91

598.76

ng/l

1.35

303

Benign neoplasms

249

1056

1.30

3.66

1.1

424.51

462.41

ng/l

0.06

243

All chronic kidney diseases

128

734

1.43

3.62

1.1

227.14

903.85

ng/l

1.60

167

Secondary and unspecified malignant neoplasm of lymph nodes

104

2.32

3.59

1.1

3929.00

170.66

ng/l

—

Injuries to the knee and lower leg

303

1331

1.26

3.58

1.1

768.81

475.14

ng/l

0.25

290

Superficial injury of abdomen, lower back and pelvis

212

1.89

3.57

1.1

737.62

331.35

ng/l

—

Lymphoid leukaemia

2.66

3.56

1.1

712.57

259.11

ng/l

—

L04AA Selective immunosuppressants

367

1.67

3.56

1.1

135.82

583.05

ng/l

0.92

Thyroiditis

2.40

3.56

1.1

20.00

315.79

ng/l

—

Chronic gastritis

375

1.66

3.54

1.1

254.44

527.33

ng/l

0.58

Superficial injury of hip and thigh

192

1.93

3.51

1.1

148.14

303.21

ng/l

—

Speech therapy

407

1.62

3.51

1.1

132.18

625.55

ng/l

1.33

Thyroiditis, ILD-related definition

151

2.06

3.50

1.1

73.00

597.07

ng/l

—

Diseases of pulp and periapical tissues, including avohilmo

266

1075

1.28

3.49

1.1

442.40

458.63

ng/l

0.02

238

Cluster headache, strict

3.89

3.49

1.0

—

50.00

—

Enterocolitis due to Clostridium difficile

138

2.11

3.48

1.0

1.1

628.71

412.36

ng/l

—

Other problems related to primary support group, including family circumstances

167

1.99

3.48

1.2

1.1

323.00

316.57

ng/l

—

Benign neoplasm of colon, rectum, anus and anal canal

148

933

1.38

3.47

1.1

441.61

700.84

ng/l

0.44

229

Metatarsalgia

112

2.24

3.47

1.1

—

357.06

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

137

984

1.39

3.47

1.1

109.70

672.93

ng/l

2.22

242

Use of anticholinesterases

331

1.62

3.47

1.1

33.35

541.28

ng/l

—

N06DA Anticholinesterases

331

1.62

3.47

1.1

33.35

541.28

ng/l

—

Disorders of adult personality and behaviour

479

1.57

3.45

1.1

659.60

399.18

ng/l

0.22

113

Diseases of arteries, arterioles and capillaries

155

837

1.37

3.41

1.1

84.32

780.94

ng/l

2.51

208

Osteoporosis

318

1.68

3.40

1.1

229.50

337.76

ng/l

0.32

Cluster headache, wide

3.77

3.39

1.0

—

50.00

—

Acetic acid derivatives and related substances

187

1.70

3.38

1.1

705.50

411.04

ng/l

0.23

Achilles tendinitis

120

2.17

3.37

1.3

1.1

98.00

313.58

ng/l

—

Varicella [chickenpox]

2.51

3.37

1.2

1.1

137.71

240.46

ng/l

—

Retinal detachments and breaks

514

1.54

3.36

1.1

130.20

807.49

ng/l

1.96

124

Other heart diseases, wide

244

1163

1.28

3.35

1.1

771.33

511.48

ng/l

0.22

256

Other CVD

246

1.79

3.34

1.1

1989.62

468.09

ng/l

—

Tinnitus

351

1.66

3.33

1.0

1.1

1607.25

640.54

ng/l

0.47

Use of pramipexole

321

1.69

3.32

1.1

4348.92

382.72

ng/l

0.65

Insulin, combination of fast acting with intermediate-acting or long-acting

145

968

1.37

3.32

1.1

218.97

616.08

ng/l

1.71

221

Early lumbar disc prolapse, operated

108

2.23

3.31

1.0

1.1

23.14

350.00

ng/l

—

Diabetic retinopathy

287

1.59

3.29

1.1

284.95

330.62

ng/l

0.13

Chronic rhinitis, nasopharyngitis and pharyngitis

493

1.54

3.28

1.2

1.1

996.56

401.95

ng/l

0.25

114

Impingement syndrome of shoulder

345

1.66

3.28

1.2

1.1

121.64

681.19

ng/l

1.90

Striking against or struck by other objects

565

1.51

3.27

1.1

2955.67

354.48

ng/l

0.41

132

Iron deficiency anaemia

645

1.47

3.27

1.1

995.39

438.22

ng/l

0.25

149

Coagulation defects, purpura and other haemorrhagic conditions

286

1.72

3.23

1.2

1.1

2358.12

416.08

ng/l

0.71

Other fall from one level to another

362

1.63

3.22

1.1

739.94

335.03

ng/l

0.37

Tuberculosis, wide

2.44

3.21

1.1

222.67

96.42

ng/l

—

Deforming dorsopathies

363

1.63

3.19

1.1

76.50

431.82

ng/l

—

Dyspnoea

218

1251

1.29

3.19

1.1

580.99

519.06

ng/l

0.07

289

Crohn disease

199

1.86

3.19

1.2

1.1

247.80

352.02

ng/l

0.16

Injury, poisoning and certain other consequences of external causes

139

501

1.39

3.18

1.1

463.93

428.73

ng/l

0.04

116

Chronic lower respiratory diseases

309

1325

1.24

3.17

1.1

468.27

557.04

ng/l

0.12

291

Malignant neoplasm of digestive organs

460

0.53

3.16

1.1

87.40

843.44

ng/l

—

109

Unspecific neurodegenerative disorder

396

1.50

3.16

1.1

32.02

460.62

ng/l

—

113

Glomerulonephritis

137

2.05

3.16

1.0

1.1

179.13

392.08

ng/l

—

Abnormal weight loss

117

2.14

3.15

1.1

307.00

446.32

ng/l

—

Other enthesopathy of foot (+metatarsalgia)

117

2.14

3.15

1.1

—

357.06

—

Hyperlipidaemia, other/unspecified

539

1.49

3.15

1.1

243.23

911.52

ng/l

1.22

131

Varicella [chickenpox]

2.64

3.13

1.3

1.1

137.71

252.68

ng/l

—

Caries of dentine

340

1.63

3.12

1.0

1.1

119.91

459.15

ng/l

1.14

Volume depletion

111

2.17

3.12

1.0

1.1

2742.00

273.32

ng/l

—

Nutritional anaemias

110

749

1.42

3.12

1.1

798.71

586.97

ng/l

0.10

182

Urticaria and erythema

621

1.47

3.11

1.1

773.38

418.78

ng/l

0.20

135

Bacterial intestinal infections, IBD co-morbidities

267

1.73

3.10

1.1

407.92

419.40

ng/l

0.01

Bipolar affective disorders

282

1.71

3.10

1.1

50.17

234.14

ng/l

1.57

Pulmonary heart disease

413

1.58

3.09

1.1

243.16

505.79

ng/l

0.68

103

Melanocytic naevi

461

1.54

3.08

1.1

63.63

519.27

ng/l

—

106

Other retinal disorders

145

834

1.36

3.07

1.1

236.00

807.04

ng/l

1.57

192

Meniscus derangement

134

656

1.38

3.06

1.1

356.19

532.52

ng/l

0.38

167

Dental caries

383

1.58

3.05

1.0

1.1

109.92

432.32

ng/l

1.22

104

Intracerebral haemorrhage

139

2.02

3.04

1.1

1654.63

577.51

ng/l

0.35

Colonic or urogenital fistula

431

1.56

3.04

1.1

2734.08

626.29

ng/l

0.35

Dermatophytosis

174

1.90

3.04

1.1

147.91

350.87

ng/l

0.64

Disorders of refraction and accommodation

422

1.56

3.02

1.1

107.64

434.54

ng/l

0.83

Insomnia

214

1218

1.28

3.01

1.1

1302.00

396.18

ng/l

0.38

276

Pulmonary embolism

416

1.56

3.01

1.1

243.16

505.79

ng/l

0.68

103

Vasomotor and allergic rhinitis

606

1.46

3.01

1.1

736.38

418.84

ng/l

0.18

132

Benign neoplasm of eye and adnexa

133

2.04

3.00

1.1

3547.00

494.36

ng/l

—

Ovarian cyst

336

1.50

3.00

1.1

1280.53

202.72

ng/l

0.41

Budesonide

189

1.86

3.00

1.1

258.33

414.19

ng/l

0.24

Crohn's disease of small intestine

100

2.21

2.99

1.2

1.1

25.86

350.57

ng/l

—

Tetraplegia

10.16

2.99

1.2

1.0

—

Hypermetropia

100

2.21

2.98

1.1

145.20

278.52

ng/l

—

Missing teeth due to accident, extraction or parodontitis

140

978

1.35

2.97

1.1

982.74

598.53

ng/l

0.31

226

Haemorrhoids and perianal venous thrombosis

472

1.52

2.97

1.1

931.94

627.37

ng/l

0.18

111

Other and unspecified iron deficiency

497

1.51

2.97

1.1

1567.82

512.49

ng/l

—

121

Sequelae of external causes of morbidity and mortality

379

1.59

2.95

1.0

1.1

191.14

347.86

ng/l

—

Erysipelas

123

791

1.38

2.94

1.1

334.26

697.52

ng/l

0.68

167

Atopic dermatitis

144

878

1.35

2.94

1.1

73.71

378.64

ng/l

1.75

179

Dental operations

150

570

1.35

2.94

1.1

467.50

284.46

ng/l

0.42

143

Other peripheral vertigo

114

2.11

2.94

1.0

1.1

128.83

463.34

ng/l

—

Endometriosis

325

1.50

2.92

1.1

662.73

200.49

ng/l

0.37

Noninfective enteritis and colitis

112

804

1.39

2.92

1.1

185.13

495.64

ng/l

0.98

182

Other acute lower respiratory infections

123

855

1.37

2.91

1.1

710.62

400.93

ng/l

0.25

193

Generalized anxiety disorder

213

1.79

2.90

1.1

26.43

432.15

ng/l

—

Tuberculosis, IBD comorbidity

2.38

2.89

1.1

222.67

96.42

ng/l

—

Intestinal malabsorption

2.51

2.87

1.1

—

347.73

—

Injuries to the wrist and hand

250

1387

1.25

2.86

1.1

1346.48

396.19

ng/l

0.71

311

Behavioural syndromes associated with physiological disturbances and physical factors

228

1282

1.26

2.86

1.1

1264.76

477.37

ng/l

0.33

293

Sudden idiopathic hearing loss

129

2.02

2.85

1.3

1.1

1626.30

593.72

ng/l

—

Diabetic maculopathy, excluding more controls

150

1.94

2.84

1.0

1.1

234.00

389.94

ng/l

—

Other disorders of patella

237

1.73

2.83

1.1

155.67

665.58

ng/l

—

Fracture of rib(s), sternum and thoracic spine

447

1.52

2.82

1.1

58.33

505.84

ng/l

—

108

Maternal care for other conditions predominantly related to pregnancy

307

1.63

2.82

1.0

1.1

48.14

518.53

ng/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

208

1.78

2.81

1.1

2688.78

484.98

ng/l

—

Other and unspecified urticaria

306

1.64

2.81

1.1

71.75

324.85

ng/l

1.43

Unspecified haematuria

531

1.44

2.80

1.1

1177.25

517.50

ng/l

0.42

137

Heart failure and coronary heart disease

505

0.60

2.80

1.0

1.1

612.13

467.08

ng/l

—

137

Weight loss

130

2.01

2.80

1.1

307.00

416.83

ng/l

—

Other diseases of pleura

599

1.42

2.80

1.1

407.47

600.79

ng/l

0.33

152

Osteoporosis with pathological fracture (FG)

2.47

2.79

1.1

1.2

69.17

489.20

ng/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

474

1.50

2.75

1.2

1.1

95.08

428.46

ng/l

0.92

105

Diseases of the digestive system

102

726

1.40

2.75

1.1

768.08

543.94

ng/l

0.14

173

Sleep disorders

217

1244

1.26

2.73

1.1

1342.97

454.20

ng/l

0.36

285

Sequelae of infectious and parasitic diseases

2.21

2.73

1.2

1.1

88.71

273.60

ng/l

—

Streptococcal septicaemia

111

2.08

2.72

1.3

1.1

141.18

340.88

ng/l

0.47

Speech and linguistic disorders

126

1.99

2.71

1.2

1.1

95.83

95.48

ng/l

—

Otitis externa, unspecified

167

1.86

2.71

1.1

165.71

364.10

ng/l

—

Special screening examination for other diseases and disorders

118

2.04

2.70

1.2

1.1

149.43

237.63

ng/l

—

Atopic dermatitis, strict definition

490

1.48

2.70

1.1

50.53

415.22

ng/l

1.15

110

Gonarthrosis [arthrosis of knee](FG)

174

779

1.30

2.69

1.1

296.36

718.05

ng/l

1.00

190

Elevated blood glucose level

105

2.10

2.68

1.2

1.1

98.67

246.50

ng/l

—

Insulin medication

145

924

1.32

2.67

1.1

218.97

732.41

ng/l

1.51

212

Allergic contact dermatitis

190

1.79

2.65

1.3

1.1

801.25

308.05

ng/l

—

Transport accidents

108

674

1.38

2.65

1.1

55.62

514.42

ng/l

2.09

168

Hypotension

205

1.76

2.64

1.1

3161.60

419.37

ng/l

—

Other diseases of stomach and duodenum

2.22

2.63

1.1

66.50

560.59

ng/l

—

Normal-pressure hydrocephalus

2.66

2.62

1.3

1.1

733.40

99.27

ng/l

—

Nonsuppurative otitis media

330

1.55

2.61

1.1

132.49

271.64

ng/l

0.54

Cardiac arrhythmias

146

718

1.32

2.61

1.1

1517.86

449.82

ng/l

0.54

163

Viral and other specified intestinal infections

416

1.51

2.60

1.1

16.20

344.64

ng/l

—

Bacterial, viral and other infectious agents

127

1.98

2.60

1.1

4257.78

207.20

ng/l

—

Statin medication

174

757

1.29

2.59

1.1

397.61

518.71

ng/l

0.21

177

Superficial injury of head

353

1.56

2.57

1.0

1.1

187.11

390.34

ng/l

—

Disorders of synovium and tendon

115

743

1.36

2.56

1.2

1.1

81.17

481.66

ng/l

3.09

196

Type 2 diabetes, wide definition

194

979

1.27

2.55

1.1

188.69

631.16

ng/l

1.35

228

Bacterial, viral and other infectious agents

135

1.93

2.55

1.1

3558.15

201.96

ng/l

—

Other obstetric conditions, not elsewhere classified

303

1.49

2.53

1.1

90.36

140.93

ng/l

0.28

Other predominantly sexually transmitted diseases, not elsewhere classified

261

1.65

2.53

1.1

51.71

351.17

ng/l

—

Secondary uncertain malignant neoplasm

164

1.83

2.52

1.1

3048.20

458.87

ng/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

3.24

2.52

1.0

1.1

—

665.20

—

Coxarthrosis [arthrosis of hip](FG)

119

620

1.35

2.51

1.1

667.36

780.08

ng/l

0.06

159

Chronic kidney disease

403

1.51

2.51

1.1

309.53

501.85

ng/l

0.40

105

Urticaria

509

1.46

2.51

1.1

76.06

427.03

ng/l

1.18

117

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

293

1.50

2.50

1.1

97.20

140.66

ng/l

—

Erysipelas

159

940

1.29

2.49

1.1

281.00

636.44

ng/l

0.83

192

Acute bronchitis

630

1.40

2.49

1.1

990.55

440.48

ng/l

0.32

137

Personality disorders

453

1.48

2.48

1.1

71.64

436.33

ng/l

1.00

102

Manic episode

3.48

2.48

1.0

1.2

—

632.40

—

Benign neoplasm: Choroid

2.20

2.47

1.1

5060.71

441.28

ng/l

—

Later onset COPD

304

0.50

2.46

1.2

1.1

185.00

546.26

ng/l

—

Paroxysmal tachycardia

284

1.56

2.45

1.1

2761.56

356.94

ng/l

—

Pruritus

137

1.90

2.45

1.0

1.1

3084.14

402.71

ng/l

—

Oxicams

172

1.62

2.44

1.2

1.1

71.00

435.66

ng/l

—

Atopic dermatitis, strict definition with reimbursement

494

1.45

2.44

1.1

50.53

393.61

ng/l

0.92

Diabetic maculopathy

149

1.84

2.44

1.0

1.1

234.00

263.05

ng/l

—

Alcohol use disorder, Swedish definition

127

880

1.32

2.44

1.1

359.85

624.53

ng/l

0.34

209

Excessive, frequent and irregular menstruation

357

1.41

2.43

1.1

66.00

192.50

ng/l

1.34

Asthma, hospital admissions , main diagnosis only

196

1382

1.25

2.43

1.1

100.26

614.16

ng/l

2.83

310

Inflammatory disease of uterus

196

1.74

2.42

1.1

116.09

201.47

ng/l

0.35

Diabetic retinopathy, strict definition

192

1.70

2.41

1.1

278.71

302.94

ng/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

383

1.52

2.41

1.1

173.60

339.82

ng/l

—

Injuries to the neck

359

1.53

2.41

1.1

206.27

310.28

ng/l

0.31

DVT of lower extremities and pulmonary embolism

611

1.40

2.40

1.1

228.60

566.80

ng/l

0.95

143

Diseases of salivary glands

506

1.44

2.40

1.1

113.60

474.08

ng/l

—

117

Lateral epicondylitis

160

1.82

2.38

1.0

1.1

86.00

304.90

ng/l

—

Disease of hard tissues of teeth, NOS

135

534

1.32

2.38

1.1

149.50

383.75

ng/l

1.13

141

Other diseases of anus and rectum

432

1.48

2.38

1.1

1152.17

665.96

ng/l

0.28

100

Thrombocytopenia, unspecified

2.07

2.37

1.2

1.1

2697.86

263.78

ng/l

—

Spondylopathies (FG)

183

1.75

2.35

1.2

1.1

685.60

485.44

ng/l

—

Explicit bacterial Sepsis

125

1.92

2.35

1.3

1.1

142.92

618.45

ng/l

1.09

Other diseases of hard tissues of teeth

139

547

1.32

2.34

1.1

281.20

379.06

ng/l

0.24

143

Other symptoms and signs involving the circulatory and respiratory systems

2.15

2.34

1.2

1.1

19.83

228.42

ng/l

—

Venous thromboembolism

116

843

1.33

2.33

1.1

836.76

634.26

ng/l

0.12

199

Purpura and other haemorrhagic conditions

191

1.73

2.33

1.2

1.1

3625.73

346.79

ng/l

0.80

Infections of the skin and subcutaneous tissue

138

1055

1.30

2.32

1.1

359.75

544.74

ng/l

0.32

242

Fibroblastic disorders

299

1.57

2.32

1.1

138.64

428.16

ng/l

1.49

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

101

466

1.37

2.31

1.1

1101.68

325.55

ng/l

0.50

114

Dislocation, sprain and strain of joints and ligaments of knee

147

1054

1.29

2.31

1.1

524.87

576.09

ng/l

0.06

227

Other pleural conditions

126

1.91

2.30

1.0

1.1

108.80

451.00

ng/l

—

Spondylolisthesis/Spondylolysis

222

1.67

2.30

1.1

61.00

629.89

ng/l

—

Monoamine oxidase A inhibitors

155

1.81

2.29

1.1

—

382.05

—

Other disorders of bone

300

1.57

2.29

1.1

33.50

402.14

ng/l

—

Open wound of head

118

861

1.32

2.28

1.1

238.46

646.13

ng/l

1.01

202

Burns and corrosions

215

1.68

2.28

1.0

1.1

146.00

218.06

ng/l

—

Fenamates

133

1.74

2.28

1.1

161.71

502.86

ng/l

—

Other and unspecified disorders of white blood cells

2.47

2.28

1.2

1.1

64.40

275.07

ng/l

—

Coronary artery bypass grafting

315

0.54

2.27

1.2

1.1

1555.28

388.86

ng/l

0.39

Crohn's disease NAS

2.07

2.27

1.2

1.1

22.57

332.71

ng/l

—

Assault

208

1.69

2.26

1.1

707.40

130.59

ng/l

—

Otitis externa

357

1.52

2.26

1.1

101.93

358.28

ng/l

1.37

Schizophrenia or delusion, excluding more controls

450

1.45

2.25

1.0

1.1

263.50

474.72

ng/l

0.40

121

134

934

1.30

2.25

1.1

346.78

594.07

ng/l

0.33

221

Other disorders of bladder

156

1.80

2.25

1.1

2653.33

643.59

ng/l

—

Other diseases of lip and oral mucosa

673

1.37

2.25

1.1

1543.30

400.12

ng/l

0.51

158

Pulmonary heart disease, diseases of pulmonary circulation

455

1.45

2.25

1.1

243.16

471.50

ng/l

0.60

111

141

965

1.29

2.23

1.1

334.75

576.37

ng/l

0.33

228

Coxarthrosis

113

559

1.34

2.23

1.1

693.67

589.01

ng/l

0.06

145

Crohn disease (strict definition, require KELA, min 2 HDR)

2.10

2.22

1.2

1.1

41.33

401.70

ng/l

—

Other disorders of the genitourinary system

164

1.77

2.22

1.2

1.1

107.79

425.31

ng/l

—

Arthrosis

166

717

1.27

2.21

1.1

207.84

491.70

ng/l

0.96

183

Gonarthrosis

147

650

1.29

2.20

1.1

314.45

533.77

ng/l

0.53

167

Other/unspecified synovitis and tenosynovitis

136

1.84

2.17

1.2

1.1

34.13

351.12

ng/l

—

Spondyloarthritis

250

1.60

2.14

1.1

573.33

393.05

ng/l

—

Hernia

224

1233

1.22

2.13

1.0

1.1

323.53

481.47

ng/l

0.34

286

Cellulitis

346

1.51

2.13

1.1

822.27

285.46

ng/l

0.46

Superficial injury of lower leg

395

1.47

2.12

1.1

40.17

569.01

ng/l

1.42

Type 1 diabetes

411

1.46

2.12

1.1

179.83

517.50

ng/l

1.02

Diverticular disease of intestine

158

797

1.27

2.11

1.1

367.85

593.62

ng/l

0.35

190

Crohn disease (strict definition, require KELA)

2.05

2.11

1.2

1.1

41.33

379.88

ng/l

—

Lesion of ulnar nerve

167

1.74

2.10

1.0

1.1

24.00

322.02

ng/l

—

Reimbursement for rheumatic diseases

132

1026

1.28

2.08

1.1

483.63

648.97

ng/l

0.22

233

Injury of nerves at lower leg level

5.05

2.07

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

211

1011

1.22

2.07

1.1

907.60

490.01

ng/l

0.40

216

Dislocation, sprain and strain of joints and ligaments at neck level

229

1.62

2.07

1.1

148.00

276.25

ng/l

—

Sequelae of injuries of neck and trunk

2.72

2.07

1.1

—

270.67

—

Acute appendicitis, no complications

129

1000

1.28

2.07

1.1

211.36

570.43

ng/l

1.12

225

Benign neoplasm of other and unspecified endocrine glands

191

1.68

2.06

1.2

1.1

155.25

405.85

ng/l

—

COPD, hospital admissions 1, only main diagnosis

435

0.61

2.05

1.1

45.20

535.99

ng/l

—

116

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

2.33

2.05

1.2

1.1

108.20

75.92

ng/l

—

Other noninfective gastroenteritis and colitis

398

1.46

2.05

1.1

39.00

370.37

ng/l

2.77

Type 1 diabetes, wide definition, subgroup 1

350

1.49

2.02

1.1

198.46

323.54

ng/l

0.53

Other abnormal uterine and vaginal bleeding

243

1.51

2.00

1.2

1.1

494.13

135.62

ng/l

0.70

Specific personality disorders

384

1.46

2.00

1.1

91.00

489.30

ng/l

—

Benign neoplasm: Transverse colon

155

1.75

1.99

1.1

82.00

499.07

ng/l

—

Pre-eclampsia

287

1.54

1.99

1.0

1.1

368.57

596.69

ng/l

—

Noninfectious colitis NAS

193

1.66

1.99

1.1

18.80

471.53

ng/l

—

Excessive attrition of teeth

130

1020

1.28

1.99

1.0

1.1

313.29

448.21

ng/l

0.26

237

Type 1 diabetes, wide definition

360

1.47

1.98

1.1

198.46

308.43

ng/l

0.47

Disorders of vitreous body

109

808

1.30

1.96

1.1

1067.52

703.18

ng/l

0.20

201

Cerebral aneurysm, nonruptured

112

1.88

1.96

1.0

1.1

—

488.81

ng/l

—

Congenital malformations, deformations and chromosomal abnormalities

137

1032

1.26

1.95

1.1

179.88

370.21

ng/l

0.92

223

Substance abuse

133

985

1.27

1.95

1.1

679.85

542.46

ng/l

0.08

232

Polycystic ovarian syndrome, consortium definition

159

753

1.25

1.94

1.1

245.03

565.38

ng/l

0.57

154

Panic disorder

195

1.64

1.92

1.1

34.50

455.34

ng/l

—

Mental and behavioural disorders due to psychoactive substance use

137

1006

1.26

1.92

1.1

679.85

538.29

ng/l

0.08

234

Keratitis

582

1.36

1.90

1.1

523.41

470.16

ng/l

0.06

134

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

442

1.41

1.88

1.1

226.33

484.48

ng/l

0.39

Other and unspecified effects of external causes

457

1.40

1.86

1.2

1.1

66.36

438.69

ng/l

1.13

107

Thyrotoxicosis

382

1.44

1.86

1.1

1081.50

543.76

ng/l

—

Arthropathies in other diseases classified elsewhere

2.40

1.85

1.0

1.2

—

587.35

—

Sequelae of other and unspecified infectious and parasitic diseases

2.03

1.85

1.1

93.67

307.52

ng/l

—

Other nutritional deficiencies

153

1163

1.24

1.84

1.1

358.56

614.44

ng/l

0.52

271

Bicipital tendinitis

2.21

1.84

1.1

1.2

—

377.84

—

Diseases of male genital organs

126

496

1.28

1.84

1.1

712.26

289.33

ng/l

0.72

124

Phobic anxiety disorders

167

1.68

1.82

1.1

25.50

344.82

ng/l

—

Fracture of lumbar spine and pelvis

285

1.51

1.82

1.1

970.89

388.63

ng/l

—

Transplanted organ and tissue status

145

1.73

1.81

1.2

1.1

1098.99

364.17

ng/l

—

Other (seronegative) rheumatoid arthritis, wide

270

1.52

1.80

1.1

200.50

385.63

ng/l

0.62

Disorders of vitreous body and globe

110

823

1.28

1.80

1.1

1067.52

699.10

ng/l

0.20

203

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1.92

1.80

1.2

1.1

41.33

361.84

ng/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.77

1.79

1.1

—

244.17

—

Congenital malformations, deformations and chromosomal abnormalities

149

1109

1.24

1.79

1.1

193.62

423.06

ng/l

1.12

245

Angina pectoris

718

0.75

1.78

1.1

1523.93

595.11

ng/l

0.40

186

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

123

1.79

1.78

1.1

582.78

620.86

ng/l

—

Excessive earwax

119

917

1.27

1.76

1.2

1.1

146.97

718.16

ng/l

1.97

223

Disorders of synovium and tendon in diseases classified elsewhere

3.35

1.75

1.0

1.1

—

633.17

ng/l

—

Renal failure

613

1.31

1.75

1.1

257.37

555.23

ng/l

0.91

158

Burns and corrosions of external body surface, specified by site

162

1.67

1.74

1.0

1.1

168.17

243.61

ng/l

—

Open wound of wrist and hand

101

766

1.29

1.72

1.2

1.1

772.45

510.72

ng/l

0.23

179

Diseases of pulp and periapical tissues and dental caries

156

648

1.23

1.68

1.1

531.72

518.08

ng/l

0.02

158

Mental and behavioural disorders due to alcohol, excluding acute intoxication

759

1.29

1.65

1.1

51.95

706.57

ng/l

3.17

179

Varicose veins of other sites

1.89

1.65

1.2

1.1

58.60

309.29

ng/l

—

Crohn disease (strict definition, all UC cases excluded)

2.04

1.64

1.1

51.33

383.35

ng/l

—

Hypertrophic disorders of skin

2.03

1.64

1.3

1.0

23.80

390.08

ng/l

—

Malignant neoplasm

200

990

1.20

1.62

1.1

907.65

490.67

ng/l

0.40

215

Torticollis

3.59

1.62

1.0

1.1

—

547.17

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.39

1.61

1.0

—

179.63

—

Type 2 diabetes

233

1155

1.18

1.61

1.1

357.03

652.98

ng/l

0.71

252

COPD related to multimorbidity

503

0.69

1.61

1.2

1.1

116.02

646.83

ng/l

2.02

131

Propionic acid derivatives

211

1.41

1.60

1.1

425.87

377.50

ng/l

0.07

Fracture at wrist and hand level

590

1.32

1.60

1.1

3195.56

498.99

ng/l

0.58

138

Thyrotoxicosis with diffuse goitre

190

1.58

1.59

1.0

1.1

1982.00

976.66

ng/l

—

Glomerular disorders in diseases classified elsewhere

159

1.64

1.58

1.1

129.00

377.65

ng/l

—

Benign neoplasm: Caecum

144

1.67

1.57

1.1

698.11

415.16

ng/l

—

Adenomyosis (Endometriosis of uterus)

183

1.59

1.56

1.0

1.1

131.60

107.08

ng/l

—

Allergic rhinitis

536

1.33

1.56

1.0

1.1

28.57

384.19

ng/l

—

120

Irregular menses

103

641

1.27

1.55

1.1

185.42

371.51

ng/l

0.42

130

Female genital prolapse

269

1.37

1.54

1.1

289.19

219.61

ng/l

—

Sequelae with surgical and medical care as external cause

289

1.46

1.54

1.0

1.1

194.00

417.62

ng/l

—

Hypertrophic scar

2.04

1.54

1.3

1.0

23.80

344.50

ng/l

—

Mental and behavioural disorders due to alcohol

113

869

1.25

1.54

1.1

48.69

587.91

ng/l

3.36

204

Benign neoplasm: Ascending colon

192

1.57

1.53

1.1

857.50

342.65

ng/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

161

1.48

1.53

1.1

1068.83

453.87

ng/l

—

GI-bleeding

449

1.36

1.53

1.1

205.71

370.85

ng/l

0.74

111

Alzheimer disease, including avohilmo

314

1.37

1.52

1.1

18.82

547.36

ng/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

130

1.70

1.52

1.2

1.1

56.40

434.50

ng/l

—

Social phobias

100

1.80

1.52

1.1

20.60

365.70

ng/l

—

Gastroduodenal ulcer

347

1.41

1.52

1.1

69.35

561.65

ng/l

1.87

Allergic urticaria

115

1.74

1.52

1.2

1.1

81.83

311.69

ng/l

—

Plantar fascial fibromatosis

115

1.74

1.52

1.2

1.1

195.50

378.65

ng/l

—

Other hearing loss

357

1.40

1.52

1.3

1.1

1186.07

502.25

ng/l

0.45

Poisoning by drugs, medicaments and biological substances

382

1.39

1.52

1.1

136.30

490.27

ng/l

—

Poisoning by medicine

340

1.41

1.51

1.1

144.22

552.10

ng/l

—

Dental caries, including avohilmo

173

735

1.20

1.51

1.1

428.78

469.90

ng/l

0.06

181

Sub-endpoint used in defining T1D endpoints

460

1.35

1.50

1.1

179.83

321.01

ng/l

0.72

101

Diseases of oral cavity, salivary glands and jaws

132

549

1.24

1.50

1.1

439.32

379.06

ng/l

0.09

143

Asthma-related pneumonia or sepsis

545

1.32

1.49

1.1

376.00

560.72

ng/l

0.21

129

Asthma, hospital admissions 3, pneumonia

545

1.32

1.49

1.1

376.00

560.72

ng/l

0.21

129

Other diseases of the digestive system

452

1.35

1.48

1.1

221.54

370.85

ng/l

0.63

111

Other arrhythmias

148

921

1.21

1.48

1.1

1061.04

543.25

ng/l

0.45

212

FESS (DNB20)

186

1.56

1.48

1.3

1.1

537.13

371.14

ng/l

—

Injury of unspecified body region

1.81

1.47

1.0

1.1

229.80

254.29

ng/l

—

Mixed and other personality disorders

109

1.75

1.46

1.0

1.1

23.60

329.54

ng/l

—

COPD, hospital admissions

591

0.73

1.46

1.2

1.1

143.87

613.22

ng/l

2.01

160

Cholecystectomy

153

1096

1.20

1.46

1.1

85.85

681.19

ng/l

2.76

259

Protozoal diseases

2.38

1.45

1.1

—

90.13

—

Non-rheumatic valve diseases

107

616

1.25

1.45

1.2

1.1

740.22

746.15

ng/l

0.00

141

Superficial injury of thorax

211

1.52

1.45

1.1

168.67

416.58

ng/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

318

1.42

1.45

1.1

51.71

310.70

ng/l

—

Caries of dentine, including avohilmo

184

789

1.19

1.45

1.1

401.73

456.01

ng/l

0.09

187

Injury of other and unspecified intrathoracic organs

1.88

1.44

1.1

—

323.60

—

Alcohol use disorder, ICD-based

699

1.27

1.44

1.1

51.95

765.50

ng/l

3.14

163

Ulcer of vagina/vulva

2.74

1.43

1.0

1.1

—

120.71

—

Disorders of gallbladder, biliary tract and pancreas

225

1216

1.17

1.43

1.1

242.92

614.83

ng/l

0.99

281

Psychotic depression

2.04

1.43

1.1

1.2

—

427.07

—

Diabetes medication

245

1253

1.16

1.43

1.1

317.27

617.58

ng/l

0.79

271

Phlebitis and thrombophlebitis (not including DVT)

336

1.40

1.43

1.1

1863.23

227.90

ng/l

0.50

Valvular heart disease excluding rheumatic fever

108

625

1.25

1.42

1.2

1.1

740.22

741.21

ng/l

0.00

142

severe traumatic brain injury, does not include concussion

303

1.42

1.41

1.1

77.00

609.64

ng/l

—

Obesity due to excess calories

104

835

1.25

1.41

1.1

436.92

469.90

ng/l

0.05

189

Asthma-related pneumonia

542

1.31

1.41

1.1

398.27

564.77

ng/l

0.18

128

Other peripheral vascular diseases

103

1.75

1.40

1.1

34.20

511.64

ng/l

—

Status post-ami

333

0.66

1.40

1.1

3217.78

273.20

ng/l

—

Alcohol abuse, main dg, excluding more controls

213

1.50

1.40

1.1

79.14

266.42

ng/l

—

Other specified disorders of muscle

2.42

1.39

1.0

1.2

—

524.21

—

Injuries to unspecified part of trunk, limb or body region

134

1.64

1.38

1.0

1.1

229.80

253.53

ng/l

—

Diabetes, varying definitions

242

1226

1.16

1.38

1.1

349.12

624.47

ng/l

0.67

265

Necrosis of pulp, including avohilmo

129

1060

1.21

1.37

1.1

119.72

553.62

ng/l

2.42

234

Other inflammation of eyelid

190

1.53

1.37

1.1

131.40

209.44

ng/l

—

Ulcer of lower limb, not elsewhere classified

182

1.54

1.36

1.1

80.63

432.40

ng/l

—

Heart failure and bmi 25plus

397

0.71

1.36

1.0

1.1

384.76

885.12

ng/l

0.55

104

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

127

826

1.22

1.36

1.1

597.11

433.01

ng/l

0.12

176

Other benign neoplasms of skin

582

1.29

1.35

1.1

519.88

537.27

ng/l

0.01

136

Diabetes mellitus

243

1231

1.15

1.35

1.1

349.11

619.90

ng/l

0.66

267

Adenocarcinoma and ductal carcinoma of pancreas

0.00

1.34

0.0

1.1

—

63.38

—

Other skin changes

257

1.44

1.33

1.1

512.80

353.34

ng/l

—

Urolithiasis

497

1.31

1.1

99.91

607.64

ng/l

1.91

121

Cardiodefibrillation

544

0.71

1.30

1.0

1.1

147.00

625.62

ng/l

—

154

Flat foot [pes planus] (acquired)

129

1.63

1.29

1.0

1.1

34.40

422.18

ng/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

309

1.39

1.29

1.1

228.43

586.16

ng/l

—

Persistent mood disorders

284

1.41

1.29

1.1

20.75

556.89

ng/l

—

Polyarthrosis

271

1.41

1.28

1.2

1.1

26.00

610.57

ng/l

1.24

Perforation of tympanic membrane

145

1.59

1.28

1.1

95.67

442.32

ng/l

—

Fracture of lower leg, including ankle

120

980

1.21

1.28

1.1

225.65

575.09

ng/l

1.22

222

Other and unspecified disorders of vitreous body

684

1.26

1.28

1.1

1501.56

766.46

ng/l

0.31

165

Undefined dementia

1.72

1.26

1.1

26.40

96.96

ng/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

121

973

1.21

1.26

1.1

226.56

506.08

ng/l

0.70

217

Disorder of lipoprotein metabolism, unspecified

186

1.51

1.26

1.1

146.38

788.19

ng/l

—

Care involving dialysis

107

1.69

1.25

1.1

113.71

537.48

ng/l

—

Unspecified dementia

1.72

1.25

1.1

26.40

375.36

ng/l

—

Thyrotoxicosis, other and/or unspecified

286

1.40

1.24

1.1

1195.11

692.84

ng/l

—

Ethmoidectomy

195

1.49

1.24

1.3

1.1

537.13

363.66

ng/l

—

Acne vulgaris

108

1.67

1.22

1.1

31.74

326.95

ng/l

—

Other Crohn's disease

1.72

1.21

1.0

1.1

54.20

365.26

ng/l

—

Anti-inflammatory and antirheumatic products, non-steroids

211

1.33

1.19

1.0

1.1

509.15

377.50

ng/l

0.19

Pre-eclampsia or eclampsia

323

1.36

1.19

1.0

1.1

368.57

560.08

ng/l

—

Endometriosis of ovary

249

1.41

1.18

1.1

1129.17

91.21

ng/l

—

Methotrexate

189

1.48

1.18

1.3

1.1

242.44

502.60

ng/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

264

1.40

1.18

1.1

94.60

360.61

ng/l

—

Congenital malformations of the circulatory system

240

1.42

1.17

1.1

103.00

314.91

ng/l

—

Haemorrhage from respiratory passages

472

1.28

1.17

1.1

944.78

433.99

ng/l

0.31

128

Hallux rigidus

198

1.47

1.16

1.1

5251.71

405.91

ng/l

—

Dialysis, with operation codes

190

1.48

1.16

1.1

167.20

427.32

ng/l

—

Other respiratory disorders and diseases

282

1.38

1.15

1.1

358.44

437.67

ng/l

—

Other diseases of the respiratory system

282

1.38

1.15

1.1

358.44

437.67

ng/l

—

COPD, hospital admission 2, with asthma infections

397

0.71

1.15

1.2

1.1

65.00

538.39

ng/l

—

102

Familial hypercholesterolemia

207

1.45

1.14

1.1

65.47

723.86

ng/l

—

Gastric ulcer

232

1.42

1.14

1.1

58.99

668.84

ng/l

1.54

Coronary atherosclerosis

103

790

0.82

1.14

1.1

477.92

561.73

ng/l

0.09

199

COPD, early/later onset

592

0.77

1.14

1.2

1.1

139.26

616.07

ng/l

2.10

159

Malignant melanoma of skin, including Hilmo

199

1.46

1.14

1.1

70.14

510.08

ng/l

—

Other and unspecified intracranial injuries

2.34

1.12

1.0

1.1

—

75.00

—

Thoracic aortic aneurysm

208

1.44

1.12

1.1

17.56

736.27

ng/l

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

175

1.49

1.12

1.0

1.1

128.20

302.16

ng/l

—

Schizophrenia

270

0.63

1.11

1.1

173.60

244.93

ng/l

—

Solid cancers, helper endpoint

190

973

1.15

1.10

1.1

888.20

494.98

ng/l

0.35

213

Adhesive capsulitis of shoulder

209

1.44

1.10

1.1

1846.44

426.45

ng/l

—

Follicular cysts of skin and subcutaneous tissue

285

1.37

1.10

1.0

1.1

143.60

408.15

ng/l

—

Artrosis, including avohilmo

195

927

1.15

1.09

1.1

186.79

464.09

ng/l

1.26

229

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

217

1146

1.14

1.09

1.1

331.25

642.46

ng/l

0.75

256

Sleep disorders, other/unspecified

1.96

1.09

1.0

—

26.75

—

Caries of enamel

209

1321

1.14

1.08

1.1

448.79

589.24

ng/l

0.19

298

Benign neoplasm: Skin of other and unspecified parts of face

136

1.55

1.08

1.1

42.60

392.19

ng/l

—

Effects of other external causes

2.19

1.08

1.0

1.1

—

958.67

—

Retinal detachment with retinal break

185

1.46

1.08

1.1

110.00

480.45

ng/l

—

Schizophrenia, schizotypal and delusional disorders

540

1.26

1.08

1.0

1.1

276.31

447.44

ng/l

0.32

124

Rheumatoid arthritis

444

1.27

1.07

1.1

157.00

626.44

ng/l

1.16

109

Cardiomyopathy

267

0.64

1.07

1.0

1.1

669.67

359.08

ng/l

—

Heart failure, strict

702

0.81

1.06

1.0

1.1

282.99

758.66

ng/l

0.93

177

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

343

1.33

1.06

1.1

411.00

640.40

ng/l

—

Fall involving bed

2.13

1.05

1.0

1.1

—

89.14

—

Heart failure,strict

655

0.81

1.05

1.0

1.1

320.37

697.94

ng/l

0.60

160

Fall on and from stairs and steps

418

1.29

1.05

1.1

107.60

359.10

ng/l

—

Papulosquamous disorders

650

1.23

1.04

1.0

1.1

446.05

554.72

ng/l

0.09

152

Squamous cell neoplasms and carcinomas of the skin

1.71

1.04

1.1

740.71

745.17

ng/l

—

Diseases of middle ear and mastoid

124

858

1.18

1.04

1.1

106.22

483.74

ng/l

1.73

180

Obesity and other hyperalimentation

137

1128

1.17

1.04

1.1

468.45

624.89

ng/l

0.25

259

Diabetic nephropathy, excluding more controls

146

1.47

1.04

1.2

1.1

233.20

432.23

ng/l

—

Suicide or other Intentional self-harm

393

1.30

1.03

1.1

81.14

497.87

ng/l

—

Exclusions for E4_PCOS_CONSORTIUM

163

882

1.16

1.02

1.1

518.33

490.21

ng/l

0.03

198

Ménière disease

114

1.58

1.02

1.2

1.1

1610.38

436.68

ng/l

—

Malignant melanoma, including Hilmo

238

1.39

1.02

1.1

70.14

447.48

ng/l

—

Allergic conjunctivitis

125

1036

1.18

1.01

1.1

220.50

487.73

ng/l

0.71

228

Leisure time condition

281

1.35

1.01

1.1

1730.90

354.61

ng/l

—

Fracture of skull and facial bones

333

1.32

1.01

1.1

112.78

441.23

ng/l

—

Gout

323

1.31

1.01

1.1

1.2

507.47

563.44

ng/l

0.06

102

Retinal vascular occlusion

155

1.49

1.00

1.1

205.67

520.68

ng/l

—

Retinal vascular disorders

155

1.49

1.00

1.1

205.67

520.68

ng/l

—

Superficial injury of ankle and foot

180

1.45

1.00

1.1

28.40

286.60

ng/l

—

Unspecified acute lower respiratory infection

222

1.40

1.00

1.1

108.36

146.33

ng/l

—

Persons encountering health services for specific procedures, not carried out

1.62

0.99

1.0

1.1

—

458.88

—

Benign neoplasm: Sigmoid colon

282

1.35

0.99

1.2

1.1

649.75

361.43

ng/l

—

Endometriosis ASRM stages 3,4

334

1.32

0.99

1.1

970.43

448.43

ng/l

—

Appendectomy

141

1161

1.16

0.99

1.1

127.24

631.18

ng/l

2.06

266

COPD

588

0.79

0.98

1.2

1.1

139.26

475.13

ng/l

1.60

152

Adalimumab

148

1.49

0.97

1.1

286.33

365.93

ng/l

—

Graves ophthalmopathy, strict

0.00

0.97

0.0

1.1

—

55.13

—

Adenocarcinoma of pancreas

0.00

0.97

0.0

1.1

—

63.29

—

Substance use, excluding alcohol

327

1.32

0.97

1.0

1.1

1841.67

311.84

ng/l

—

Ganglion

275

1.35

0.96

1.1

51.80

366.69

ng/l

—

Malignant melanoma

190

1.42

0.96

1.1

80.00

530.98

ng/l

—

Early onset COPD, excluding more controls

258

1.36

0.96

1.2

1.1

111.82

618.42

ng/l

—

Calculus of kidney and ureter

460

1.26

0.95

1.1

99.40

517.38

ng/l

—

109

All-cause Heart Failure

693

0.82

0.95

1.0

1.1

282.99

767.05

ng/l

0.95

175

Graves ophthalmopathy

0.00

0.95

0.0

1.1

—

55.13

—

Pleural plaque without asbestos

0.00

0.95

0.0

1.1

—

62.50

—

Other superficial mycoses

149

1.48

0.95

1.1

89.50

249.34

ng/l

—

Blepharochalasis

443

1.27

0.94

1.1

1156.50

809.35

ng/l

0.18

111

Diseases of appendix

164

1292

1.14

0.94

1.1

213.23

504.84

ng/l

1.10

297

Pacemaker

426

0.74

0.94

1.0

1.1

503.17

438.58

ng/l

—

117

Other metabolic disorders

191

1.42

0.94

1.0

1.1

130.17

305.51

ng/l

—

Male infertility

1.78

0.94

1.0

1.1

—

359.28

—

Cholelithiasis

179

1083

1.14

0.94

1.1

59.02

662.30

ng/l

2.75

251

Volvulus

2.23

0.93

1.2

1.1

—

57.60

—

Myocardial infarction, strict

595

0.81

0.93

1.1

456.61

532.71

ng/l

0.09

158

Inflammatory bowel disease

534

1.24

0.92

1.2

1.1

221.33

489.95

ng/l

0.59

120

Paracetamol or NSAID medication

120

1.39

0.92

1.0

1.1

270.20

340.52

ng/l

—

Psoriatic and enteropathic arthropathies

150

1.47

0.92

1.0

1.1

1351.50

464.08

ng/l

—

Other chronic obstructive pulmonary disease

560

0.79

0.92

1.2

1.1

139.26

490.61

ng/l

1.61

145

Obesity

135

1126

1.16

0.92

1.1

468.45

492.32

ng/l

0.04

257

Disorders of continuity of bone

134

1.49

0.91

1.2

1.1

91.20

555.61

ng/l

—

Cholelithiasis, broad definition with cholecystitis

186

1105

1.13

0.90

1.1

91.30

651.28

ng/l

2.48

256

Gingivitis and periodontal diseases

236

1088

1.12

0.90

1.1

642.43

576.56

ng/l

0.06

257

Any event in cancer register

206

1077

1.13

0.89

1.1

969.21

461.30

ng/l

0.52

230

Benign neoplasm of breast

168

1.43

0.89

1.2

1.1

568.60

382.02

ng/l

—

Other menopausal disorders

269

0.75

0.89

1.0

1.1

48.00

220.67

ng/l

—

Primary open-angle glaucoma, strict

366

1.28

0.89

1.3

1.1

2134.89

558.37

ng/l

0.37

Coxarthrosis, primary

115

833

1.17

0.89

1.1

680.96

700.09

ng/l

0.01

210

Schizophrenia or delusion

537

1.23

0.89

1.0

1.1

263.50

453.81

ng/l

0.35

123

Lichen ruber planus, wide definition including periferal and oral lichen planus

332

1.30

0.89

1.1

86.00

326.09

ng/l

—

222

1.36

0.88

1.1

362.00

773.21

ng/l

0.57

Vascular dementia

1.65

0.88

1.2

1.1

27.20

120.05

ng/l

—

Other and unspecified nonorganic psychotic disorders

315

1.30

0.88

1.0

1.1

498.17

304.48

ng/l

—

Sulfasalazine

448

1.25

0.88

1.1

933.71

504.44

ng/l

0.36

Early lumbar disc prolapse operation

169

1.42

0.87

1.0

1.1

23.14

260.76

ng/l

—

Medical treatment for female infertility

314

1.30

0.86

1.0

1.1

83.00

527.76

ng/l

—

Contusion of ankle

1.82

0.86

1.0

1.1

—

25.43

—

Acne

136

1.47

0.85

1.1

31.74

274.73

ng/l

—

Single spontaneous delivery

346

0.80

0.85

1.1

216.92

197.82

ng/l

0.04

Pleural effusion

196

1.38

0.83

1.0

1.1

131.30

664.72

ng/l

—

Adverse effects, not elsewhere classified

309

1.30

0.83

1.2

1.1

71.00

346.43

ng/l

—

Polyp of the female genital tract

288

1.24

0.83

1.1

49.72

213.94

ng/l

1.45

COPD, hospital admissions 3, with asthma pneumonia sepsis

323

0.74

0.83

1.2

1.1

65.00

574.63

ng/l

—

Car occupant injured in other and unspecified transport accidents

283

1.31

0.83

1.1

59.00

351.33

ng/l

—

Corneal ulcer

292

1.30

0.82

1.2

1.1

328.67

343.00

ng/l

—

Acute renal failure

301

1.30

0.82

1.1

121.25

626.62

ng/l

—

IBD patients in KELA-register

372

1.26

0.82

1.2

1.1

107.00

289.47

ng/l

0.96

Other diseases of pancreas

113

1.51

0.82

1.2

1.1

156.33

526.53

ng/l

—

Macular cyst

1.88

0.82

1.0

1.1

—

141.13

—

Appendicitis, broad definition

161

1288

1.13

0.81

1.1

213.23

506.29

ng/l

1.10

296

Acute appendicitis

151

1244

1.13

0.81

1.1

213.23

527.03

ng/l

1.18

283

Fall on same level involving ice and snow

117

1015

1.15

0.80

1.0

1.1

1605.07

501.58

ng/l

0.39

239

Acute and transient psychotic disorders

181

1.38

0.79

1.1

526.17

227.52

ng/l

—

Cholecystitis

181

1.38

0.79

1.2

1.1

205.67

477.46

ng/l

0.74

Benign neoplasm: Lip

0.00

0.79

0.0

1.1

—

37.40

—

Gout, FINNGEN

382

1.25

0.79

1.1

507.47

672.12

ng/l

0.18

101

Postmenopausal bleeding

226

1.25

0.78

1.0

1.1

103.54

250.88

ng/l

0.86

Atrial fibrillation and flutter

317

1.23

0.78

1.0

1.1

2335.44

364.74

ng/l

—

Diabetic nephropathy

188

1.37

0.77

1.2

1.1

233.20

319.41

ng/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

0.77

0.0

1.0

—

70.60

—

Acute suppurative otitis media

426

1.23

0.76

1.1

171.54

293.86

ng/l

0.49

Trigger finger

174

1.38

0.76

1.1

56.43

369.62

ng/l

—

Benign neoplasm: Rectum, anus and anal canal

296

1.28

0.76

1.1

569.44

414.36

ng/l

—

Malignant cancer of tonsil and base of tongue

0.00

0.76

0.0

1.1

—

55.70

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

0.76

0.0

1.1

—

68.15

—

Other coagulation defects

1.52

0.75

1.1

32.60

276.00

ng/l

—

Palmar fascial fibromatosis [Dupuytren]

192

1.36

0.74

1.2

1.1

70.40

449.53

ng/l

—

Coeliac disease

184

1.36

0.73

1.3

1.1

2190.29

381.72

ng/l

—

Peripheral retinal degeneration

1.85

0.73

1.0

1.1

—

45.00

ng/l

—

Salpingitis and oophoritis

254

1.30

0.73

1.2

1.1

111.78

700.96

ng/l

—

Aortic aneurysm

310

1.27

0.72

1.1

18.09

561.11

ng/l

—

Contact with sharp glass

1.80

0.72

1.0

1.1

—

685.88

—

Ischaemic heart disease, wide definition

134

940

0.88

0.72

1.1

413.15

579.59

ng/l

0.22

227

Endometriosis of pelvic peritoneum

234

1.30

0.72

1.1

66.60

145.14

ng/l

—

Alcohol abuse, main dg

246

1.30

0.71

1.1

79.14

208.59

ng/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

211

1.33

0.71

1.3

1.1

41.33

497.23

ng/l

—

Preterm labour and delivery

416

1.23

0.71

1.2

1.1

4681.88

461.53

ng/l

—

Disorders of tooth development and eruption

213

1.29

0.71

1.1

67.83

268.29

ng/l

—

Other chronic obstructive pulmonary disease, including avohilmo

720

0.85

0.70

1.1

117.56

544.43

ng/l

2.31

188

Glaucoma

106

794

1.15

0.70

1.2

1.1

1350.83

605.86

ng/l

0.26

192

Rheumatoid arthritis, including avohilmo

609

1.18

0.70

1.2

1.1

144.50

469.51

ng/l

1.17

140

Retinal breaks without detachment

247

1.30

0.70

1.2

1.1

77.20

437.90

ng/l

—

Diabetes, insulin treatment (Kela reimbursement)

222

1218

1.10

0.70

1.1

326.41

623.80

ng/l

0.75

272

Inflammatory bowel disease, strict (require KELA)

381

1.23

0.70

1.2

1.1

107.00

279.95

ng/l

0.89

Other specified/unspecified disorders of bone/cartilage

1.71

0.70

1.0

1.1

—

534.66

—

Insulin, fast-acting (human)

212

1.32

0.70

1.1

101.14

262.11

ng/l

—

Colon adenocarcinoma

142

0.63

0.69

1.1

—

513.07

—

Malignant neoplasm of colon

181

0.66

0.69

1.1

—

574.68

—

Medical abortion

128

611

1.14

0.69

1.1

992.93

471.65

ng/l

0.29

132

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

208

1208

1.10

0.68

1.1

773.02

404.23

ng/l

0.42

270

Mental retardation, excluding more controls

1.66

0.68

1.1

—

518.00

—

Pedal cyclist injured in transport accident

365

1.23

0.67

1.1

21.89

303.87

ng/l

—

Other disorders of amniotic fluid and membranes

183

1.33

0.67

1.2

1.1

34.60

222.35

ng/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

267

1.27

0.66

1.1

228.89

261.42

ng/l

—

Persons with potential health hazards related to communicable diseases

662

1.17

0.66

1.1

97.20

412.33

ng/l

1.07

131

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

285

1.26

0.66

1.1

271.09

257.82

ng/l

0.03

Other articular cartilage disorders

1.79

0.66

1.0

1.2

—

40.50

—

Injury of muscle and tendon at lower leg level

232

1.29

0.66

1.1

120.13

456.44

ng/l

—

Haemorrhagic and haematological disorders of fetus and newborn

1.60

0.65

1.1

1.0

—

78.50

—

Procreative management

511

1.18

0.65

1.1

382.00

227.50

ng/l

0.26

102

Psoriasis

458

1.20

0.65

1.0

1.1

690.92

596.20

ng/l

0.05

104

Other surgical follow-up care

1.73

0.64

1.0

1.1

—

375.78

—

Benign neoplasm: Rectum

269

1.27

0.63

1.1

631.63

345.90

ng/l

—

Biological medication for rheuma

287

1.26

0.63

1.1

218.00

345.53

ng/l

0.37

Bronchitis, not specified as acute or chronic

112

1.43

0.63

1.1

1275.60

292.89

ng/l

—

Peritonsillar abscess

314

1.24

0.63

1.1

490.20

506.00

ng/l

—

Paralytic ileus and intestinal obstruction

350

1.23

0.63

1.1

263.63

496.45

ng/l

—

Non-invasive ventilation

329

1.22

0.62

1.1

135.50

273.10

ng/l

—

Melanoma in situ

1.64

0.62

1.1

—

111.00

ng/l

—

Impetigo

1.59

0.61

1.1

—

439.36

—

Scabies

1.59

0.61

1.2

1.1

—

388.61

—

Injury of muscle and tendon at wrist and hand level

208

1.30

0.61

1.1

114.63

363.13

ng/l

—

Multiple myeloma

1.67

0.61

1.0

1.2

—

52.14

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.67

0.61

1.0

1.2

—

52.14

—

Post-traumatic wound infection, not elsewhere classified

1.67

0.61

1.0

1.1

—

736.17

—

Benign lipomatous neoplasm

479

0.81

0.61

1.2

1.1

141.88

686.64

ng/l

—

112

Benign neoplasm of other and ill-defined parts of digestive system

253

1.27

0.60

1.1

72.86

468.46

ng/l

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.60

0.0

1.2

—

71.67

—

Pre-eclampsia or poor fetal growth

461

1.19

0.59

1.0

1.1

323.75

441.37

ng/l

—

Malignant neoplasm of tonsil

0.00

0.59

0.0

1.1

—

38.78

—

Seborrhoeic keratosis

326

1.23

0.59

1.1

212.57

630.20

ng/l

—

Superficial injury of wrist and hand

326

1.23

0.59

1.1

116.67

288.23

ng/l

0.77

Malignant neoplasm of oropharynx

0.00

0.58

0.0

1.1

—

38.78

—

Supervision of normal pregnancy

204

0.78

0.58

1.1

4179.60

92.20

ng/l

—

Dependent personality disorder

0.00

0.58

0.0

1.1

—

57.00

—

Malignant melanoma of skin

149

1.34

0.57

1.2

1.1

80.00

562.97

ng/l

—

Actinic keratosis

490

1.17

0.57

1.1

1345.00

319.01

ng/l

0.83

127

Later onset COPD, excluding more controls

196

0.75

0.57

1.2

1.1

185.00

548.87

ng/l

—

DVT of lower extremities

247

1.26

0.56

1.2

1.1

196.60

256.79

ng/l

—

Anorexia (incl.atypical)

0.57

0.56

1.0

1.1

—

267.75

ng/l

—

Lichen planus

185

1.30

0.56

1.1

91.14

454.97

ng/l

—

Diseases of liver

550

1.16

0.55

1.1

62.71

655.30

ng/l

2.06

124

Other specified/unspecified bacterial intestinal infections

1.45

0.55

1.2

1.1

98.80

137.95

ng/l

—

Atrial fibrillation and flutter with reimbursement

243

1.20

0.55

1.0

1.1

511.00

430.29

ng/l

—

Antenatal screening

211

0.80

0.55

1.1

588.14

90.06

ng/l

—

Seropositive rheumatoid arthritis, strict definition

217

0.74

0.54

1.1

72.20

419.44

ng/l

—

Pyothorax

1.50

0.54

1.1

—

391.92

—

Postpartum care and examination

138

0.73

0.54

1.3

1.1

95.00

95.95

ng/l

—

Gonarthrosis,primary

182

1026

1.09

0.54

1.1

398.75

665.83

ng/l

0.47

251

Benign neoplasm: Colon, unspecified

376

1.20

0.54

1.1

1013.60

515.97

ng/l

0.44

Other/unspecified enthesopathies, not elsewhere classified

1.42

0.54

1.1

7016.60

445.16

ng/l

—

Skin changes due to chronic exposure to nonionizing radiation

500

1.16

0.53

1.1

1257.73

317.23

ng/l

0.81

128

Delivery

347

0.85

0.53

1.1

220.13

197.83

ng/l

0.06

Postmenopausal atrophic vaginitis

237

0.81

0.53

1.3

1.1

402.45

252.45

ng/l

0.17

Foreign body in alimentary tract

1.49

0.53

1.1

—

317.46

—

Malignant neoplasm of skin

557

1.13

0.53

1.1

582.00

729.02

ng/l

0.12

128

Female infertility

300

1.17

0.53

1.1

110.09

195.68

ng/l

0.41

Supplementary factors related to causes of morbidity and mortality classified elsewhere

516

1.16

0.52

1.0

1.1

1446.92

293.64

ng/l

0.41

120

Acute alcohol intoxication

405

1.19

0.52

1.1

65.11

423.75

ng/l

2.41

Degenerative macular diseases

152

1.32

0.52

1.1

209.43

553.70

ng/l

—

Polycythaemia vera

1.50

0.51

1.3

1.2

—

57.33

—

Type of accident

480

1.17

0.51

1.0

1.1

1446.92

322.27

ng/l

0.40

107

525

1.15

0.51

1.1

1385.38

574.17

ng/l

0.64

132

Neonatal jaundice from other and unspecified causes

1.49

0.51

1.2

1.1

—

87.43

—

Endometriosis ASRM stages 1,2

260

1.23

0.51

1.1

66.60

611.95

ng/l

—

Other (not insulin) diabetes medications

209

1146

1.08

0.50

1.1

312.54

636.69

ng/l

0.80

255

Abnormal findings in secretions and smears from cervix uteri vagina vulva

639

1.12

0.50

1.1

56.79

416.33

ng/l

1.43

131

Other diseases of oesophagus

118

1.36

0.50

1.1

—

473.31

—

Other abnormal products of conception

342

1.16

0.50

1.1

85.64

222.95

ng/l

0.55

Dislocation, sprain and strain of joint and ligaments of hip

1.56

0.49

1.1

—

105.44

—

5-aminosalicylic acid

326

1.20

0.48

1.1

150.70

282.83

ng/l

—

Pregnancy, childbirth and the puerperium

238

0.83

0.47

1.1

93.22

186.45

ng/l

—

Maternal care for known or suspected abnormality of pelvic organs

272

0.83

0.47

1.0

1.1

29.40

296.05

ng/l

—

Eating disorders

154

0.71

0.47

1.0

1.1

—

205.27

ng/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

409

1.15

0.46

1.1

447.22

565.72

ng/l

0.10

Pedal cyclist injured in other and unspecified transport accidents

155

1.29

0.46

1.2

1.1

23.57

263.67

ng/l

—

Nephropathy related operations

182

1.26

0.46

1.1

190.75

335.41

ng/l

—

Other respiratory diseases principally affecting the interstitium

243

0.78

0.45

1.1

710.86

327.25

ng/l

—

Dermatophytosis

121

1101

1.10

0.45

1.1

267.46

636.98

ng/l

0.97

265

Other gastritis (incl. Duodenitis)

320

1.19

0.44

1.2

1.1

72.57

566.83

ng/l

—

Congenital malformations of the urinary system

1.40

0.44

1.1

1.0

395.50

78.93

ng/l

—

Primary open-angle glaucoma

435

1.16

0.44

1.3

1.1

2026.26

505.73

ng/l

0.38

108

Multiple myeloma, including Hilmo

1.37

0.44

1.3

1.1

—

50.99

—

Other noninflammatory disorders of uterus, except cervix

221

1.19

0.44

1.1

43.70

150.62

ng/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

130

1.31

0.43

1.4

1.1

39.00

234.48

ng/l

—

Seropositive rheumatoid arthritis, wide

405

0.84

0.43

1.1

132.58

593.71

ng/l

1.08

Acute alcohol intoxication, ICD10

330

1.18

0.43

1.1

70.28

323.12

ng/l

—

Heart failure and antihypertensive medication

239

1.18

0.43

1.0

1.1

459.77

319.73

ng/l

—

Gestational diabetes (for exclusion)

404

1.14

0.43

1.1

130.17

407.99

ng/l

0.47

Abrasion of teeth

576

0.87

0.43

1.1

769.00

442.58

ng/l

—

130

Redundant prepuce, phimosis and paraphimosis

327

1.18

0.43

1.1

763.50

286.80

ng/l

—

Arthropathic psoriasis

166

1.27

0.43

1.0

1.1

1613.20

447.71

ng/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

104

1.35

0.43

1.4

1.1

39.00

269.80

ng/l

—

Dissection of aorta

1.62

0.43

1.0

1.1

—

112.86

—

Single delivery by caesarean section

158

0.80

0.42

1.1

4177.20

189.77

ng/l

—

Malignant neoplasm of colon, including Hilmo

240

0.79

0.42

1.1

—

462.12

—

Kidney transplant status

1.38

0.42

1.1

136.40

270.64

ng/l

—

Non-ischemic cardiomyopathy

420

0.86

0.42

1.0

1.1

68.06

288.50

ng/l

2.13

107

Spontaneous rupture of synovium and tendon

1.36

0.41

1.3

1.1

126.40

425.71

ng/l

—

Biguanides

203

1155

1.07

0.41

1.1

325.92

627.20

ng/l

0.71

262

Other disorders of the musculoskeletal system and connective tissue

213

1.22

0.40

1.1

22.64

412.70

ng/l

—

Nasal polyp

268

1.19

0.40

1.1

820.83

350.83

ng/l

—

Pterygium

1.47

0.40

1.2

1.1

—

113.57

—

Arterial embolism and thrombosis of lower extremity artery

1.47

0.40

1.0

1.1

—

63.14

—

Periapical abscess

805

1.11

0.40

1.0

1.1

2170.45

622.75

ng/l

0.36

189

L04AD Calcineurin inhibitors

177

1.24

0.40

1.0

1.1

109.88

429.31

ng/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.40

0.0

1.1

—

51.80

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

106

774

1.10

0.39

1.1

148.24

812.76

ng/l

1.94

187

Contraceptive management

557

1.11

0.39

1.1

985.37

227.48

ng/l

0.75

113

Other diseases of liver

269

1.19

0.39

1.1

104.71

329.63

ng/l

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.43

0.39

1.2

1.1

—

587.17

—

Autoimmune hyperthyroidism

1.41

0.39

1.0

1.1

1982.00

587.67

ng/l

—

Normotensive glaucoma

106

1.32

0.39

1.5

1.1

93.57

470.14

ng/l

—

Malignant neoplasm of breast, HER-positive

406

1.13

0.39

1.1

472.12

572.03

ng/l

0.08

Pregnancy hypertension

620

1.11

0.38

1.1

207.13

373.01

ng/l

0.36

131

Other and unspecified vascular occlusions

124

1.29

0.38

1.1

63.20

582.22

ng/l

—

Other/unspecified seropositive rheumatoid arthritis

399

0.85

0.38

1.1

132.58

593.71

ng/l

1.08

Unstable angina pectoris

491

0.88

0.38

1.1

1360.08

467.34

ng/l

0.31

136

Persons encountering health services in circumstances related to reproduction

123

763

1.09

0.37

1.1

1529.54

228.83

ng/l

0.84

157

Benign neoplasm: Skin of lower limb, including hip

1.35

0.37

1.0

1.1

—

83.33

—

Occupational exposure to risk-factors

1.35

0.37

1.2

1.1

—

708.43

ng/l

—

Asthma/COPD (KELA code 203)

205

1321

1.06

0.36

1.1

210.17

557.04

ng/l

1.12

291

Congenital malformations of the urinary system

1.36

0.36

1.1

1.0

314.40

81.86

ng/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

482

0.89

0.36

1.0

1.1

178.22

630.33

ng/l

—

135

Conduction disorders

395

1.13

0.35

1.1

1358.75

393.01

ng/l

0.35

Unspecified mental disorder

697

1.10

0.35

1.0

1.1

212.20

386.84

ng/l

0.43

159

1.42

0.35

1.0

1.1

—

78.50

ng/l

—

Injuries to the hip and thigh

683

1.10

0.35

1.1

896.69

471.98

ng/l

0.41

156

Myocardial infarction, without ST-elevation

531

1.12

0.35

1.1

525.33

583.40

ng/l

0.07

147

Primary gonarthrosis, bilateral

736

1.09

0.35

1.1

102.32

798.41

ng/l

2.10

184

Fall on and from ladder

108

1.30

0.35

1.0

1.1

56.60

242.42

ng/l

—

In situ neoplasms

574

1.12

0.35

1.1

581.80

548.78

ng/l

—

134

Sequelae of injuries of lower limb

135

1.26

0.35

1.1

—

246.09

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

395

0.86

0.35

1.1

132.58

599.71

ng/l

1.08

Hyperplasia of prostate

346

1.12

0.35

1.1

1612.21

327.87

ng/l

1.02

Other disorders of veins

675

1.10

0.35

1.0

1.1

2240.65

328.48

ng/l

0.44

149

Long labour

329

0.86

0.35

1.0

1.1

23.20

551.86

ng/l

—

Disorders of parathyroid gland

270

1.17

0.34

1.1

62.58

297.86

ng/l

—

Haemorrhage in early pregnancy

431

1.13

0.34

1.1

3221.18

489.89

ng/l

0.39

Maternal care for cervical incompetence

1.33

0.33

1.0

1.1

—

605.73

—

Haemangioma, any site

118

1.27

0.33

1.0

1.1

104.80

462.86

ng/l

—

Seborrhoeic dermatitis

118

1.27

0.33

1.1

1212.50

303.03

ng/l

—

Injuries to the elbow and forearm

143

1174

1.07

0.33

1.0

1.1

97.44

640.61

ng/l

2.50

268

Type 2 diabetes, definitions combined

201

1113

1.06

0.33

1.1

382.04

644.80

ng/l

0.56

248

Artificial joint operation, meniscal resection

187

1144

1.06

0.32

1.1

306.02

635.18

ng/l

0.95

269

Noninflammatory disorders of female genital tract

365

1.10

0.32

1.1

415.81

189.93

ng/l

0.34

Smoking dependency

128

1.25

0.31

1.1

3227.20

242.73

ng/l

—

Mental and behavioural disorders due to tobacco

128

1.25

0.31

1.1

3227.20

242.73

ng/l

—

Gout, idiopatic and unspecified

351

1.14

0.31

1.1

507.47

529.23

ng/l

0.02

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

686

1.09

0.31

1.1

207.13

370.84

ng/l

0.37

142

Glaucoma suspect

560

1.11

0.31

1.2

1.1

107.82

608.12

ng/l

1.67

129

Periodontitis

202

1278

1.06

0.31

1.1

679.37

559.45

ng/l

0.10

300

Combinations of oral blood glucose lowering drugs

465

1.12

0.31

1.1

126.22

743.36

ng/l

2.02

113

1.29

0.30

1.0

1.1

—

63.60

ng/l

—

Haemangioma and lymphangioma, any site

129

1.24

0.30

1.0

1.1

104.80

436.43

ng/l

—

Endovascular or surgical operations to intracerebral aneurysms

1.33

0.30

1.0

1.1

—

590.86

—

Synovial cyst of popliteal space [Baker]

1.31

0.30

1.0

1.1

—

357.59

—

Other neurotic disorders

1.27

0.30

1.0

1.1

—

384.56

—

Tumor necrosis factor alpha inhibitors

259

1.16

0.29

1.1

257.70

358.54

ng/l

—

Suppurative and unspecified otitis media

566

1.10

0.29

1.1

169.00

300.24

ng/l

0.68

114

Peripheral artery disease

518

0.91

0.29

1.1

150.00

660.62

ng/l

2.01

144

Carbimazole or st.post thyroidectomy, condition for graves disease

326

1.14

0.28

1.1

92.57

602.15

ng/l

—

Bacterial pneumonia, not elsewhere classified

535

0.90

0.28

1.1

145.13

264.15

ng/l

0.78

122

Other specified/unspecified hearing loss

112

1.25

0.28

1.4

1.1

68.40

522.58

ng/l

—

Mucosal proctocolitis

186

1.18

0.27

1.1

189.13

414.32

ng/l

—

Toxic effect of contact with venomous animals

1.27

0.27

1.1

1.0

—

410.46

—

Major coronary heart disease event excluding revascularizations

106

757

0.93

0.27

1.1

913.12

669.38

ng/l

0.15

198

Fracture of femur

302

0.87

0.27

1.0

1.1

578.17

504.97

ng/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

454

0.92

0.27

1.1

2143.60

277.82

ng/l

—

Bacterial pneumonia (organism specified)

652

0.92

0.26

1.1

144.50

383.55

ng/l

1.24

154

Struck by thrown, projected or falling objec

1.19

0.26

1.3

1.1

—

410.49

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.26

0.26

1.0

1.1

—

307.94

ng/l

—

Mental retardation, wide definition

1.19

0.26

1.1

—

324.37

—

Non-small cell lung cancer, adenocarcinoma

1.25

0.25

1.1

—

153.64

ng/l

—

Maternal care for other known or suspected fetal problems

230

0.88

0.25

1.2

1.1

83.63

171.32

ng/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

1.22

0.25

1.1

—

525.28

ng/l

—

Chronic periodontitis, including avohilmo

200

1279

1.05

0.25

1.1

662.26

559.45

ng/l

0.09

300

Myocardial infarction

628

0.93

0.25

1.1

389.68

526.78

ng/l

0.20

163

Fracture of shoulder and upper arm

540

1.09

0.24

1.1

93.13

420.63

ng/l

1.16

129

Type 2 diabetes, strict (exclude DM1)

200

1121

1.05

0.24

1.1

368.35

643.85

ng/l

0.60

252

Glucosamine medication

616

1.08

0.24

1.1

2324.79

381.15

ng/l

0.51

147

Type 2 diabetes, definitions combined, including avohilmo

201

1118

1.05

0.24

1.1

472.58

604.42

ng/l

0.22

248

Single delivery by forceps and vacuum extractor

119

1.16

0.23

1.2

1.1

115.20

222.89

ng/l

—

Disorders of breast

755

1.07

0.23

1.1

387.38

546.78

ng/l

0.18

165

Malignant neoplasm of breast

466

1.08

0.23

1.1

334.82

513.01

ng/l

0.18

Bacterial pneumoniae

574

0.92

0.23

1.1

154.39

362.43

ng/l

0.86

133

Benign neoplasm: Skin of eyelid, including canthus

218

1.15

0.23

1.2

1.1

213.60

410.07

ng/l

—

Delayed milestone in childhood

1.25

0.22

1.0

1.1

—

43.67

—

Other disorders involving the immune mechanism, not elsewhere classified

1.25

0.22

1.2

1.1

—

401.67

—

Emphysema

0.74

0.22

1.0

1.1

—

258.19

—

Use of galantamine

1.27

0.22

1.0

1.1

—

373.45

—

Sulfonylureas

401

0.91

0.22

1.0

1.1

152.00

519.45

ng/l

1.21

105

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.1

—

Seminoma of testis

0.00

0.21

0.0

1.1

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

0.21

0.0

1.1

—

Fracture of forearm

105

908

1.06

0.21

1.0

1.1

75.96

567.16

ng/l

1.68

209

Alcoholic liver disease

154

1.17

0.21

1.1

17.00

226.77

ng/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.16

0.21

1.0

—

40.17

—

Spontaneous abortion

541

0.93

0.21

1.1

159.06

529.49

ng/l

0.61

115

Pregnancy examination and test

148

1.13

0.20

1.2

1.1

44.75

109.35

ng/l

—

Acute peritonitis

1.25

0.20

1.0

1.1

—

220.64

—

Other maternal disorders predominantly related to pregnancy

107

635

1.06

0.20

1.2

1.1

1735.33

410.52

ng/l

0.36

134

Gout, strict definition

250

0.88

0.20

1.1

886.50

726.05

ng/l

—

Mixed conductive and sensorineural hearing loss

155

1.16

0.19

1.1

47.38

530.95

ng/l

—

L02BA Anti-estrogens

231

1.13

0.19

1.2

1.1

54.71

787.20

ng/l

—

Heart failure, not strict

150

974

1.05

0.19

1.1

718.62

645.36

ng/l

0.06

226

Delivery, wide proxy

277

0.92

0.19

1.1

235.38

209.23

ng/l

0.06

Nonischemic cardiomyopathy

143

0.84

0.18

1.0

1.1

121.50

363.62

ng/l

—

Nontoxic multinodular goitre

251

1.12

0.18

1.1

459.17

671.26

ng/l

—

Lichen planus, including avohilmo

280

1.11

0.18

1.1

95.56

373.18

ng/l

—

COPD (mode)

333

1.09

0.18

1.1

144.68

780.43

ng/l

0.81

Multiple myeloma and malignant plasma cell neoplasms

1.21

0.18

1.3

1.1

—

285.47

—

Crowding of teeth, including avohilmo

118

0.84

0.18

1.2

1.1

25.83

224.00

ng/l

—

Gout, unspecified

290

1.10

0.18

1.1

654.36

609.07

ng/l

0.03

Labour and delivery complicated by fetal stress [distress]

240

1.09

0.17

1.2

1.1

132.00

177.03

ng/l

—

Malignant neoplasm of breast, HER2-negative

462

1.06

0.17

1.1

349.62

523.05

ng/l

0.17

Glucagon-like peptide-1 (GLP-1) analogues

513

1.07

0.17

1.1

611.14

851.03

ng/l

0.25

115

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

513

1.07

0.17

1.1

611.14

851.03

ng/l

0.25

115

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

532

1.06

0.17

1.0

1.1

650.10

734.67

ng/l

0.06

127

Chronic periodontitis, complicated

103

972

1.05

0.17

1.1

845.74

512.03

ng/l

0.17

241

Ankylosing spondylitis, strict definition

1.13

0.17

1.1

—

409.18

—

Ulcerative colitis (strict definition, require KELA)

262

1.11

0.17

1.2

1.1

149.90

355.34

ng/l

—

Supervision of high-risk pregnancy

193

0.90

0.17

1.0

1.1

616.83

100.81

ng/l

—

Familial hypercholesterolemia, with ischemic heart disease

129

1.16

0.17

1.2

1.1

36.40

427.63

ng/l

—

L01XE Protein kinase inhibitors

0.73

0.17

1.0

1.1

—

547.54

—

Open bite

0.73

0.17

1.4

1.1

—

58.00

—

Hallux valgus (acquired)

390

1.07

0.16

1.1

353.15

711.68

ng/l

0.54

Ulcerative colitis

398

1.08

0.16

1.1

120.79

334.47

ng/l

1.00

Benign leiomyoma with endometriosis

215

1.12

0.16

1.1

96.20

239.23

ng/l

—

Malignant neoplasm of breast, HER-negative

277

1.10

0.16

1.1

97.43

757.53

ng/l

—

Cutaneous abscess, furuncle and carbuncle

418

1.08

0.16

1.2

1.1

61.55

267.41

ng/l

1.93

Gonarthrosis, primary, with knee surgery

785

0.95

0.16

1.1

236.21

747.87

ng/l

1.18

200

Arthropod-borne viral fevers and viral haemorrhagic fevers

283

1.10

0.15

1.2

1.1

435.50

435.31

ng/l

—

Percutaneous Coronary Intervention

166

982

1.04

0.15

1.1

81.45

514.75

ng/l

1.70

232

Varicose veins

112

810

1.04

0.15

1.1

341.59

323.57

ng/l

0.03

179

Myocardial infarction, with ST-elevation

234

0.90

0.15

1.1

643.41

703.21

ng/l

—

malignant neoplasm of female genital organs

191

0.88

0.15

1.0

1.1

28.67

222.38

ng/l

—

Ischemic heart diseases

175

1017

1.03

0.14

1.1

337.76

506.90

ng/l

0.28

237

Acute pancreatitis (for exclusion)

306

0.91

0.14

1.1

1164.00

369.17

ng/l

—

Presbycusis

130

1.14

0.14

1.1

—

495.95

—

malignant neoplasm of male genital organs

274

1.07

0.13

1.1

504.50

729.60

ng/l

0.22

Malignant neoplasm of corpus uteri

1.17

0.13

1.0

1.1

18.20

182.54

ng/l

—

Umbilical hernia

442

1.06

0.13

1.0

1.1

95.91

426.05

ng/l

1.87

107

Pedestrian injured in transport accident

1.18

0.12

1.2

1.1

—

280.85

—

Complications of labour and delivery

116

623

1.04

0.11

1.1

1611.54

375.97

ng/l

0.43

129

Acute pancreatitis

302

0.93

0.11

1.1

1164.00

472.14

ng/l

—

Deep bite

176

1.10

0.11

1.1

32.33

200.45

ng/l

—

Embedded and impacted teeth

359

1.06

0.11

1.1

280.78

141.70

ng/l

—

Dermatographic urticaria

1.16

0.11

1.0

1.1

—

184.29

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

250

1.08

0.10

1.2

1.1

435.50

450.95

ng/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

485

1.05

0.10

1.1

351.56

456.19

ng/l

—

111

Anomalies of dental arch relationship, including avohilmo

305

1.06

0.10

1.1

115.78

324.65

ng/l

—

Female infertility, cervical, vaginal, other or unspecified origin

296

1.05

0.10

1.1

129.13

195.68

ng/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

218

0.92

0.10

1.2

1.1

207.43

365.58

ng/l

—

Scar conditions and fibrosis of skin

1.14

0.10

1.2

1.0

—

64.33

—

Kela-code for severe mental illness

616

0.96

0.10

1.1

226.29

417.69

ng/l

0.42

141

Invasive ventilation

106

1.13

0.09

1.1

357.50

233.00

ng/l

—

Malignant neoplasm of corpus uteri, including Hilmo

106

1.13

0.09

1.0

1.1

18.20

286.03

ng/l

—

Obstructed labour due to maternal pelvic abnormality

217

0.92

0.09

1.2

1.1

136.00

797.93

ng/l

—

Complications predominantly related to the puerperium

390

1.05

0.08

1.2

1.1

238.50

502.61

ng/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.83

0.08

1.0

1.1

—

357.40

—

Pregnancy with abortive outcome

121

615

1.03

0.08

1.1

853.50

468.86

ng/l

0.22

133

Mental retardation

1.09

0.08

1.1

—

320.80

—

Postpartum hemorraghe, all women as controls

375

1.05

0.08

1.1

119.60

429.18

ng/l

—

Nontoxic goitre/thyroid nodule

450

0.96

0.08

1.1

319.23

812.68

ng/l

0.58

103

Laparoscopic right hemicolectomy

1.04

0.07

1.1

—

376.68

—

Abnormal serum enzyme levels

440

1.04

0.07

1.1

190.54

735.50

ng/l

1.71

118

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

255

1.06

0.07

1.2

1.1

149.90

355.34

ng/l

—

Medicines for HER+ breast cancer

559

1.03

0.07

1.1

447.22

706.32

ng/l

0.28

118

Polypectomy (DHB20)

0.88

0.06

1.3

1.1

—

249.39

—

Etanercept

0.89

0.06

1.1

—

268.09

—

Idiopathic gout

132

0.91

0.06

1.1

73.33

396.97

ng/l

—

Degeneration of macula and posterior pole

572

1.03

0.06

1.1

254.65

838.30

ng/l

1.18

141

Contact with and exposure to communicable diseases

526

0.97

0.06

1.1

123.25

409.67

ng/l

—

107

Alcohol dependence

437

0.96

0.06

1.2

1.1

38.40

393.91

ng/l

—

109

Seropositive rheumatoid arthritis

354

0.96

0.06

1.1

132.58

1061.99

ng/l

1.21

Malignant neoplasm of prostate

259

1.04

0.06

1.1

538.13

750.87

ng/l

0.20

Early onset COPD

335

1.04

0.06

1.2

1.1

111.82

432.88

ng/l

—

False labour

295

1.04

0.05

1.0

1.1

84.75

213.62

ng/l

—

Ventral hernia

354

0.96

0.05

1.0

1.1

845.40

336.04

ng/l

—

Coronary revascularization (ANGIO or CABG)

163

983

1.01

0.05

1.1

81.79

514.75

ng/l

1.69

232

Malignant neoplasm of breast, HER2-negative, including Hilmo

474

1.02

0.05

1.1

334.25

504.30

ng/l

0.17

101

Malignant neoplasm of breast, including Hilmo

474

1.02

0.05

1.1

334.25

504.30

ng/l

0.17

101

Emergency coronary revascularization (for ACS)

173

1038

1.01

0.04

1.1

79.03

579.05

ng/l

2.25

248

Coxarthrosis, primary, with hip surgery

679

0.98

0.04

1.1

42.71

773.48

ng/l

2.27

173

Presence of cardiac and vascular implants and grafts

509

0.98

0.04

1.1

1215.27

490.64

ng/l

0.42

123

Basal cell carcinoma

488

1.02

0.04

1.0

1.1

756.41

798.78

ng/l

0.03

116

Other malignant neoplasms of skin (=non-melanoma skin cancer)

504

1.02

0.04

1.0

1.1

719.00

791.96

ng/l

0.05

117

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

121

1.07

0.03

1.2

1.1

—

471.35

—

Inguinal hernia

111

731

1.01

0.03

1.1

1609.56

375.34

ng/l

0.82

172

Ulcerative colitis, NAS

210

1.05

0.03

1.3

1.1

178.63

378.91

ng/l

—

Primary coxarthrosis, bilateral

409

1.03

0.03

1.1

1996.88

534.66

ng/l

—

103

Postpartum haemorrhage

346

0.97

0.03

1.1

119.60

565.76

ng/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

305

0.97

0.03

1.1

97.43

702.03

ng/l

—

Diabetes mellitus in pregnancy

321

0.98

0.03

1.2

1.1

96.78

530.17

ng/l

—

Other appendicitis

118

0.93

0.02

1.0

1.1

—

280.30

—

Obesity, other/unspecified

579

1.02

0.02

1.1

349.40

457.28

ng/l

—

119

Effects of foreign body entering through natural orifice

410

1.02

0.02

1.1

179.20

287.92

ng/l

—

Non-allergic asthma

122

1.06

0.02

1.0

1.1

—

448.96

—

Psoriasis vulgaris

291

1.03

0.02

1.0

1.1

907.44

417.04

ng/l

—

Leiomyoma of uterus

113

633

1.01

0.02

1.1

153.54

621.30

ng/l

0.96

146

330

0.98

0.02

1.1

341.71

568.66

ng/l

0.41

Calcific aortic valvular stenosis, including rheumatic fever

369

1.02

0.02

1.1

428.50

511.33

ng/l

—

100

L02BG Aromatase inhibitors

477

0.98

0.01

1.1

498.75

804.24

ng/l

0.29

101

Viral warts

327

0.98

0.01

1.1

47.20

271.10

ng/l

—

Gestational [pregnancy-induced] hypertension

382

1.02

0.01

1.2

1.1

62.63

500.43

ng/l

—

Postpartum hemorraghe, parous women as controls

346

0.98

0.00

1.1

119.60

433.00

ng/l

—

Overexertion and strenuous or repetitive movements

146

0.96

0.00

1.1

86.40

250.92

ng/l

—

Contact with machinery

164

1.04

0.00

1.2

1.1

3660.60

348.61

ng/l

—

AV-block

233

0.98

0.00

1.1

110.20

347.09

ng/l

—

Hernia of abdominal wall

774

1.01

0.00

1.0

1.1

348.33

650.78

ng/l

0.50

191

Major coronary heart disease event

170

1022

1.00

0.00

1.1

159.10

583.58

ng/l

1.48

241

Intestinal stricture

465

0.99

0.00

1.1

303.90

471.43

ng/l

—

117

D07AA Corticosteroids, weak (group I)

247

1.01

0.00

1.2

1.1

113.80

390.31

ng/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

297

1.01

0.00

1.2

1.1

142.82

329.23

ng/l

0.64

Calcific aortic valvular stenosis

368

1.00

0.00

1.1

428.50

511.33

ng/l

—

100

Calcific aortic valvular stenosis, operated

368

1.00

0.00

1.1

428.50

511.33

ng/l

—

100

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

222

0.99

0.00

1.1

37.86

432.13

ng/l

—

Carcinoma in situ of skin

105

1.05

0.00

1.0

1.1

—

421.26

ng/l

—

Operations 2 for CAVS

368

1.00

0.00

1.1

428.50

511.33

ng/l

—

100

Calcific aortic valvular stenosis, diagnosis (helper)

368

1.00

0.00

1.1

428.50

511.33

ng/l

—

100

Other arthrosis

630

1.00

0.00

1.1

164.50

529.67

ng/l

—

164

Malignant neoplasm of prostate, including Hilmo

270

0.99

0.00

1.1

538.13

731.05

ng/l

0.18

Basal cell carcinoma, including avohilmo

507

1.01

0.00

1.1

756.41

772.67

ng/l

0.01

120

Obstructed labour due to malposition and malpresentation of fetus

331

0.99

0.00

1.1

684.33

498.49

ng/l

—

Impacted teeth

274

1.01

0.00

1.1

30.29

178.20

ng/l

—

Other congenital malformations of skin

113

0.97

0.00

1.0

1.1

—

231.53

—

Otitis media, unspecified

169

0.98

0.00

1.1

97.80

227.84

ng/l

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.0

1.1

—

Discontinuity and dislocation of ear ossicles

0.00

0.0

1.1

—

Effects of air pressure and water pressure

0.00

0.0

1.1

—

0.00

0.0

1.0

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.0

1.0

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.0

—

Olecranon bursitis

0.87

0.00

1.0

1.1

—

279.20

—

Pityriasis rosea

0.00

0.0

1.1

—

Cleft lip

0.00

0.0

1.0

—

Dacryoadenitis

0.00

0.0

1.0

—

Lower leg

0.00

0.0

1.0

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.2

—

Thoracic root disorders

0.00

0.0

1.0

—

Typhoid and paratyphoid fevers

0.00

0.0

1.0

—

Carcinoma in situ of breast, lobular

0.00

0.0

1.0

—

Atrioventricular septal defect

0.00

0.0

1.0

—

Arterial embolism and thrombosis

1.00

-0.00

1.0

1.1

—

115.14

—

Mucinous and mucinous cystic tumor of rectum

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.2

—

Enterobiasis

0.00

-0.00

0.0

1.0

—

Whooping cough

0.00

-0.00

0.0

1.0

—

Placental disorders

0.00

-0.00

0.0

1.0

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of floor of mouth

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

1.1

—

Idiopathic hypercalciuria

0.00

-0.00

0.0

1.1

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Mastocytosis

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of gum

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.2

—

Lung transplant status

0.00

-0.00

0.0

1.1

—

Reiter disease

0.00

-0.00

0.0

1.1

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.2

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

1.0

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at neck level

0.00

-0.00

0.0

1.2

—

Left side

0.00

-0.00

0.0

1.0

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

1.0

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.2

—

Other obstetric trauma

0.98

-0.00

1.0

1.1

—

444.80

ng/l

—

Mental and behavioural disorders due to hallucinogens

0.00

-0.00

0.0

1.2

—

Cyst of spleen

0.00

-0.00

0.0

1.0

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.0

—

Mitochondrial myopathy

0.00

-0.00

0.0

1.0

—

Hypertension, portal

0.00

-0.00

0.0

1.2

—

Congenital ichthyosis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Floor of mouth

0.00

-0.00

0.0

1.2

—

Purulent endophthalmitis

0.00

-0.00

0.0

1.1

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

Rheumatic fever without mention of heart involvement

0.00

-0.00

0.0

1.0

—

ILD medications: pirfenidone

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of penis, including Hilmo

0.00

-0.00

0.0

1.1

—

Epileptic seizures related to alcohol

0.00

-0.00

0.0

1.1

—

Hepatic failure, not elsewhere classified

0.98

-0.00

1.4

1.1

—

316.68

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

-0.00

0.0

1.2

—

Acanthosis nigricans

0.00

-0.00

0.0

1.2

—

Alcoholic cardiomyopathy

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

-0.00

0.0

1.2

—

Osteomalacia

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of palate, including Hilmo

0.00

-0.00

0.0

1.0

—

Progressive systemic sclerosis

0.00

-0.00

0.0

1.0

—

Balanced rearrangements and structural markers, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Pre-eclampsia superimposed on chronic hypertension

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.1

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.2

—

Deaf mutism, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS